Please sign in to follow a disease.
Human disease
MONDO:0700096Also known as: human disease or disorder
105739 clinical trials for this condition and its sub-types, 15 tagged with Human disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Human disease
-
Disease by body system or component 0 trials · 93,739 incl. sub-types
19 sub-types
- Nervous system disorder 245 trials · 26,588 incl. sub-types Sub-types →
- Digestive system disorder 168 trials · 16,300 incl. sub-types Sub-types →
- Cardiovascular disorder 1,115 trials · 15,366 incl. sub-types Sub-types →
- Immune system disorder 151 trials · 12,959 incl. sub-types Sub-types →
- Endocrine system disorder 78 trials · 12,469 incl. sub-types Sub-types →
- Musculoskeletal system disorder 220 trials · 12,013 incl. sub-types Sub-types →
- Respiratory system disorder 150 trials · 10,848 incl. sub-types Sub-types →
- Reproductive system disorder 15 trials · 8,533 incl. sub-types Sub-types →
- Hematologic disorder 174 trials · 8,503 incl. sub-types Sub-types →
- Syndromic disease 25 trials · 7,133 incl. sub-types Sub-types →
- Urinary system disorder 72 trials · 5,523 incl. sub-types Sub-types →
- Breast disorder 25 trials · 4,686 incl. sub-types Sub-types →
- Connective tissue disorder 70 trials · 4,637 incl. sub-types Sub-types →
- Integumentary system disorder 0 trials · 4,553 incl. sub-types Sub-types →
- Disorder of visual system 1 trial · 3,476 incl. sub-types Sub-types →
- Disorder of orbital region 3 trials · 3,149 incl. sub-types Sub-types →
- Mouth disorder 21 trials · 1,910 incl. sub-types Sub-types →
- Otorhinolaryngologic disease 15 trials · 1,319 incl. sub-types Sub-types →
- Auditory system disorder 0 trials · 705 incl. sub-types Sub-types →
-
Disease by etiologic mechanism 0 trials · 59,996 incl. sub-types
5 sub-types
- Cancer or benign tumor 0 trials · 33,018 incl. sub-types Sub-types →
- Disease of genetic or genomic mechanism 2 trials · 18,330 incl. sub-types Sub-types →
- Disease of primarily extrinsic mechanism 0 trials · 10,578 incl. sub-types Sub-types →
- Nutritional disorder 132 trials · 4,162 incl. sub-types Sub-types →
- Idiopathic disease 1 trial · 1,282 incl. sub-types Sub-types →
-
Disease by developmental or physiological process 0 trials · 36,161 incl. sub-types
12 sub-types
- Psychiatric disorder 483 trials · 12,298 incl. sub-types Sub-types →
- Inflammatory disease 348 trials · 10,833 incl. sub-types Sub-types →
- Metabolic disease 245 trials · 7,349 incl. sub-types Sub-types →
- Disorder of development or morphogenesis 0 trials · 5,170 incl. sub-types Sub-types →
- Sleep disorder 507 trials · 2,089 incl. sub-types Sub-types →
- Disease by molecular mechanism 2 trials · 1,826 incl. sub-types Sub-types →
- Obstetric disorder 22 trials · 1,019 incl. sub-types Sub-types →
- Ulcer disease 58 trials · 141 incl. sub-types Sub-types →
- Mitochondrial disease 40 trials · 132 incl. sub-types Sub-types →
- Premature aging syndrome 6 trials · 109 incl. sub-types Sub-types →
- Disorder of glycosylation 0 trials · 74 incl. sub-types Sub-types →
- Perinatal disease 42 trials Sub-types →
-
Acute disease 22 trials · 4,745 incl. sub-types
119 sub-types
- Acute leukemia 123 trials · 2,241 incl. sub-types Sub-types →
- Acute respiratory failure 153 trials · 588 incl. sub-types Sub-types →
- Acute kidney injury 415 trials Sub-types →
- Acute myocardial infarction 200 trials · 369 incl. sub-types Sub-types →
- Acute coronary syndrome 298 trials
- Acute stress disorder 57 trials · 157 incl. sub-types Sub-types →
- Acute pancreatitis 101 trials · 113 incl. sub-types Sub-types →
- Encephalitis 25 trials · 95 incl. sub-types Sub-types →
- Acute lung injury 90 trials
- Acute graft versus host disease 86 trials
- Acute cholangitis 7 trials · 42 incl. sub-types Sub-types →
- Acute diarrhea 10 trials · 42 incl. sub-types Sub-types →
- Leukemia, acute lymphocytic, susceptibility to, 1 41 trials
- Poliomyelitis 28 trials · 39 incl. sub-types Sub-types →
- Acute opioid poisoning 36 trials
- Acute transplant rejection 36 trials
- Acute chest syndrome 30 trials
- Severe acute respiratory syndrome 30 trials
- Acute bronchiolitis 19 trials
- Recurrent acute pancreatitis 19 trials
- Acute liver failure 16 trials Sub-types →
- Acute myocarditis 15 trials · 16 incl. sub-types Sub-types →
- Acute quadriplegic myopathy 14 trials
- Sudden hearing loss disorder 0 trials · 14 incl. sub-types Sub-types →
- Acute pyelonephritis 13 trials
- Acute intestinal ischemia 12 trials
- Acute transverse myelitis 11 trials Sub-types →
- Subacute cutaneous lupus erythematosus 11 trials
- Acute pericementitis 0 trials · 8 incl. sub-types Sub-types →
- Acute cystitis 7 trials Sub-types →
- Acute mountain sickness 7 trials
- Acute laryngitis 1 trial · 6 incl. sub-types Sub-types →
- Acute pharyngitis 6 trials
- Acute tonsillitis 6 trials
- Acute intermittent porphyria 5 trials
- Acute urate nephropathy 4 trials
- Subacute bacterial endocarditis 4 trials
- Acute cor pulmonale 3 trials
- Acute orbital inflammation 0 trials · 3 incl. sub-types Sub-types →
- Acute tricyclic antidepressant poisoning 3 trials
- Encephalopathy, acute, infection-induced 2 trials · 3 incl. sub-types Sub-types →
- Acute hepatitis B virus infection 2 trials
- Acute thyroiditis 0 trials · 2 incl. sub-types Sub-types →
- Alcohol sensitivity, acute 2 trials
- Acute closed-angle glaucoma 1 trial
- Acute conjunctivitis 0 trials · 1 incl. sub-types Sub-types →
- Acute endophthalmitis 1 trial
- Acute flaccid myelitis 1 trial
- Acute generalized exanthematous pustulosis 1 trial
- Acute hypotension 1 trial
- Acute idiopathic urticaria 1 trial
- Acute inflammatory demyelinating polyradiculoneuropathy 1 trial
- Acute lichenoid pityriasis 1 trial Sub-types →
- Acute proliferative glomerulonephritis 0 trials · 1 incl. sub-types Sub-types →
- Acute radiation syndrome 1 trial
- Acute zonal occult outer retinopathy 1 trial
- Autoimmune autonomic ganglionopathy 1 trial
- Myoglobinuria, acute recurrent, autosomal recessive 1 trial
- Purulent acute otitis media 1 trial
- Subacute delirium 1 trial
- Marburg acute multiple sclerosis 0 trials
- Acute ackee fruit intoxication 0 trials
- Acute adrenal insufficiency 0 trials Sub-types →
- Acute annular outer retinopathy 0 trials
- Acute bilirubin encephalopathy 0 trials
- Acute cervicitis 0 trials Sub-types →
- Acute cholinergic dysautonomia 0 trials
- Acute dacryoadenitis 0 trials
- Acute dacryocystitis 0 trials
- Acute diffuse glomerulonephritis 0 trials
- Acute encephalopathy with biphasic seizures and late reduced diffusion 0 trials
- Acute endometritis 0 trials Sub-types →
- Acute ethmoiditis 0 trials
- Acute eustachian salpingitis 0 trials
- Acute fatty liver of pregnancy 0 trials
- Acute female pelvic peritonitis 0 trials
- Acute fibrinous and organizing pneumonia 0 trials
- Acute frontal sinusitis 0 trials
- Acute gonococcal epididymo-orchitis 0 trials
- Acute gonococcal prostatitis 0 trials
- Acute hepatitis C virus infection 0 trials
- Acute hydrops keratoconus 0 trials
- Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome 0 trials
- Acute inflammation of lacrimal passage 0 trials Sub-types →
- Acute insulin response 0 trials
- Acute interstitial pneumonia 0 trials
- Acute laryngopharyngitis 0 trials
- Acute lymphoblastic leukemia congenital sporadic aniridia 0 trials
- Acute macular neuroretinopathy 0 trials
- Acute mast cell leukemia 0 trials
- Acute maxillary sinusitis 0 trials
- Acute motor and sensory axonal neuropathy 0 trials
- Acute motor axonal neuropathy 0 trials
- Acute neonatal citrullinemia type I 0 trials
- Acute otitis externa 0 trials Sub-types →
- Acute papillary necrosis 0 trials
- Acute poisoning by drugs with membrane-stabilizing effect 0 trials
- Acute posterior multifocal placoid pigment epitheliopathy 0 trials
- Acute poststreptococcal glomerulonephritis 0 trials
- Acute pure sensory neuropathy 0 trials
- Acute retinal necrosis syndrome 0 trials
- Acute retrobulbar neuritis 0 trials
- Acute rheumatic heart disease 0 trials
- Acute salpingitis 0 trials Sub-types →
- Acute sensory ataxic neuropathy 0 trials
- Acute sphenoidal sinusitis 0 trials
- Acute transudative otitis media 0 trials Sub-types →
- Acute tympanitis 0 trials
- Bilateral acute depigmentation of the iris 0 trials
- Idiopathic acute eosinophilic pneumonia 0 trials
- Leukemia, acute lymphocytic, susceptibility to, 2 0 trials
- Leukemia, acute myelocytic, with polyposis coli and colon cancer 0 trials
- Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate 0 trials
- Necrotizing encephalomyelopathy, subacute, of Leigh, adult 0 trials
- Seminal vesicle acute gonorrhea 0 trials
- Subacute bursitis 0 trials
- Subacute glomerulonephritis 0 trials
- Subacute inflammatory demyelinating polyneuropathy 0 trials
- Surfactant metabolism dysfunction, pulmonary, 1 0 trials
Most studied deeper sub-types
Showing the 400 most recently updated of 3140 trials in this tab.
-
Can a Patient's own immune cells fight ovarian cancer?
Cure Stopped earlyResearchers test a personalized cancer immunotherapy called Cellgram-DC in people with advanced or recurrent epithelial ovarian cancer. The treatment uses a patient's own dendritic cells, a type of immune cell, to try to trigger an immune response against the tumor. Participants …
Phase 1 • Sponsor: Pharmicell Co., Ltd. • Aim: Cure
Last updated Sep 20, 2026 00:00 UTC
-
Cell therapy targets a marker on myeloma cells
Cure Stopped earlyResearchers are testing a cell therapy called OPC-415 in adults with multiple myeloma that has come back or stopped responding to standard treatments. Participants must have the MMG49 antigen on their cancer cells and have already tried at least two prior regimens. The trial meas…
Phase 1/2 • Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Cure
Last updated Sep 16, 2026 00:00 UTC
-
Can a One-Time gene therapy fix fabry disease for years?
Cure Stopped earlyThis study follows people with Fabry disease who have already received FLT190, an experimental gene therapy that delivers a working copy of the GLA gene. The goal is to see how safe the treatment is over the long term and whether its effects last. Researchers will track participa…
Phase 1/2 • Sponsor: Spur Therapeutics • Aim: Cure
Last updated Sep 05, 2026 00:00 UTC
-
Can a single gene infusion rewrite the story of fabry disease?
Cure Stopped earlyThis trial is testing a gene therapy called FLT190 in adult men with classic Fabry disease, a genetic condition that causes harmful fat buildup in cells. The therapy uses a modified virus to deliver a working copy of the faulty gene, potentially enabling the body to produce the m…
Phase 1/2 • Sponsor: Spur Therapeutics • Aim: Cure
Last updated Sep 05, 2026 00:00 UTC
-
Sanofi's COVID vaccine trial ends early – what we know
Vaccine Stopped earlyThis Phase 3 study tested two Sanofi COVID-19 vaccines (one targeting the original virus, another targeting two variants) in about 24,000 adults. The goal was to see if they could prevent COVID-19 safely. The trial was terminated early, so final results are limited, but the data …
Phase 3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Vaccine
Last updated Jun 27, 2026 13:00 UTC
-
New pill takes aim at stubborn blood sugar
Disease control Stopped earlyResearchers are testing an experimental oral drug called MBX-102 in adults with type 2 diabetes whose blood sugar remains too high on metformin alone. The trial compares two doses of MBX-102 with a placebo and with Actos, an approved diabetes drug. About 242 participants take the…
Phase 2 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for rare, aggressive cancers: immune therapy targets hard-to-treat tumors
Disease control Stopped earlyThis study tests a drug called tarlatamab, which helps the immune system find and attack cancer cells. It is for people with advanced neuroendocrine carcinomas of the digestive system or unknown origin, a rare and aggressive cancer with limited treatment options. About 87 partici…
Phase 2 • Sponsor: Grupo Espanol de Tumores Neuroendocrinos • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for lung scarring? trial of GSK3915393 cut short
Disease control Stopped earlyThis study tested a new medicine, GSK3915393, in 158 people with idiopathic pulmonary fibrosis (IPF), a chronic lung disease that causes scarring and breathing difficulty. The goal was to see if the drug could slow lung function decline compared to a placebo. The trial was termin…
Phase 2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can intensified chemotherapy before surgery clear bladder tumors?
Disease control Stopped earlyResearchers test whether four cycles of dose-dense MVAC chemotherapy, given with G-CSF support, can shrink or eliminate muscle-invasive bladder cancer before radical surgery. The trial enrolls 24 adults with locally advanced urothelial carcinoma of the bladder who are fit for cis…
Phase 2 • Sponsor: Pusan National University Yangsan Hospital • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Oral drug RVU120 put to the test against advanced solid tumors
Disease control Stopped earlyResearchers are testing an experimental oral drug called RVU120 in adults with advanced or metastatic solid tumors that have worsened after standard treatments. The trial has two parts: first, they check safety and find the best dose; second, they measure how well the drug shrink…
Phase 1/2 • Sponsor: Ryvu Therapeutics SA • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Experimental drug targets dangerous calcium spike in cancer
Disease control Stopped earlyResearchers are testing an experimental drug called JMT103 in adults with cancer whose blood calcium levels are dangerously high and who have not responded to standard intravenous bisphosphonate treatment. Participants receive JMT103 as an injection under the skin every four week…
Phase 1/2 • Sponsor: Shanghai JMT-Bio Inc. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can an experimental pill block a cancer-driving enzyme in hard-to-treat leukemia?
Disease control Stopped earlyResearchers are testing RVU120, an experimental oral drug, in adults with acute myeloid leukemia (AML) that has come back or stopped responding to treatment, or with high-risk myelodysplastic syndrome (MDS). The drug blocks two enzymes called CDK8 and CDK19, which may play a role…
Phase 1 • Sponsor: Ryvu Therapeutics SA • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug bulevirtide tracked in real-world hepatitis d patients
Disease control Stopped earlyThis study follows 170 people with chronic hepatitis D who are taking bulevirtide to see how well it works over time and what side effects may occur. Researchers will track serious liver problems like liver failure, cancer, or need for transplant. The goal is to understand the dr…
Sponsor: Gilead Sciences • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New combo therapy shows promise for kids with tough cancers
Disease control Stopped earlyThis study tested a combination of an immunotherapy drug (nivolumab) and low-dose chemotherapy in children and teenagers whose solid tumors had not responded to standard treatments. The goal was to see if the combination was safe and could help control the cancer. The trial was s…
Phase 1/2 • Sponsor: Centre Oscar Lambret • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a smartphone app keep heart failure patients out of the hospital?
Disease control Stopped earlyResearchers are testing a mobile app designed to help people with heart failure manage their condition after leaving the hospital. The app sends personalized messages about low-sodium food choices and alerts based on daily symptom reports. The trial enrolls 62 adults recently hos…
Phase 3 • Sponsor: University of Michigan • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New combo aims to outperform keytruda in lung cancer
Disease control Stopped earlyThis phase 3 trial tests whether adding vibostolimab to pembrolizumab (Keytruda) helps people with PD-L1 positive metastatic non-small cell lung cancer live longer than pembrolizumab alone. Over 1,200 participants received either the combination or pembrolizumab every three weeks…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New drug aims to slow Alzheimer's in early stages
Disease control Stopped earlyThis study tests an experimental drug called GSK4527226 in 367 people with early Alzheimer's (mild memory problems or mild dementia). Participants receive either a low dose, high dose, or placebo through an IV. The goal is to see if the drug can slow down declines in memory and d…
Phase 2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Heart failure patients monitored in massive new registry
Disease control Stopped earlyThis study is a large registry that will follow 5,000 people with heart failure who have received a Barostim implant. The goal is to see how well the device works in everyday medical practice to improve symptoms and quality of life. Participants are already implanted and will be …
Sponsor: CVRx, Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Promising combo for cervical cancer hits roadblock: trial ends early
Disease control Stopped earlyThis phase 2 trial tested a new treatment sequence for stage IB2 to IVA cervical cancer. Patients received a combination of gemcitabine and cisplatin chemotherapy along with radiation, followed by more gemcitabine. The goal was to see if this approach could improve progression-fr…
Phase 2 • Sponsor: Centre Oscar Lambret • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a CDK8/CDK19 blocker help when leukemia and MDS return?
Disease control Stopped earlyResearchers are testing an experimental drug called RVU120 in adults with acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) that has come back or stopped responding to treatment. RVU120 blocks two proteins, CDK8 and CDK19, that may help cancer cells grow. T…
Phase 2 • Sponsor: Ryvu Therapeutics SA • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Double-Drug attack on Hard-to-Treat lymphomas
Disease control Stopped earlyResearchers are testing whether combining two chemotherapy drugs, pralatrexate and romidepsin, is safe and effective for people with lymphoid cancers that have returned or stopped responding to treatment. The trial first finds the highest dose people can tolerate, then gives that…
Phase 1/2 • Sponsor: Jennifer Amengual • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New hope for myelofibrosis patients: experimental drug RVU120 enters Mid-Stage trial
Disease control Stopped earlyThis Phase 2 trial tests a new drug called RVU120, alone or with the standard drug ruxolitinib, in 230 adults with intermediate or high-risk myelofibrosis. The main goal is to see if the drug can shrink the spleen and improve symptoms. Participants must have not responded well to…
Phase 2 • Sponsor: Ryvu Therapeutics SA • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New combo tackles tough melanoma
Disease control Stopped earlyThis phase II trial is testing whether a combination of two drugs, rigosertib and pembrolizumab, can help people with advanced melanoma that no longer responds to standard immunotherapy. The study involves 7 participants with unresectable or metastatic melanoma. The goal is to se…
Phase 2 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
ALS drug trial halted: ARGX-119 fails to show promise
Disease control Stopped earlyThis study tested an experimental drug called ARGX-119 in 60 adults with ALS. The goal was to see if it was safe and could help with muscle function. The trial was stopped early because early results showed it was unlikely to make a meaningful difference. No safety concerns trigg…
Phase 2 • Sponsor: argenx • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
MRI-Guided radiation: a sharper aim for HPV cancers?
Disease control Stopped earlyThis early-phase trial tests whether using MRI scans to guide the placement of internal radiation (brachytherapy) can improve treatment for women with advanced cervical or vaginal cancers linked to HPV. The study involves 26 participants and compares MRI-guided placement to stand…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Liver cancer patients get immunotherapy before surgery in new trial
Disease control Stopped earlyThis study tested giving immunotherapy drugs before surgery to people with liver cancer that could be removed. The goal was to see if these drug combinations could shrink the tumor or eliminate it before the operation. 62 participants took part in this early-phase trial, which ha…
Phase 1/2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Ear drops after tube surgery: do they prevent blockage?
Disease control Stopped earlyThis study looked at whether using antibiotic ear drops during and after ear tube surgery reduces the chance of tube blockage or ear drainage in children. Only 9 children took part, and each child received drops in one ear but not the other. The study was stopped early, so the fi…
Phase 4 • Sponsor: Boston Children's Hospital • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Could a blood pressure drug combo tame panic attacks?
Disease control Stopped earlyThis phase 2 trial tests a new drug called HB-1, which combines two blood pressure medicines (telmisartan and verapamil), to see if it can reduce unexpected panic attacks in people with panic disorder. The study plans to enroll 240 adults aged 18 to 65 and compare HB-1 against pl…
Phase 2 • Sponsor: HB BioTech, LLC • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Baby shampoo and mouthwash may fight COVID-19, study finds
Disease control Stopped earlyThis study tested whether using a baby shampoo nasal wash and Listerine mouthwash for 4 days could lower the amount of COVID-19 virus in the nose and throat of recently infected adults aged 18-65. Participants were randomly assigned to different wash combinations, including plain…
Phase 2/3 • Sponsor: Milton S. Hershey Medical Center • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New Sjögren's drug ASP5502 enters first human tests
Disease control Stopped earlyThis early-stage study tested a new oral drug, ASP5502, for primary Sjögren's syndrome, an autoimmune condition causing dry eyes and mouth. It involved 116 healthy adults and patients to check safety and how the body processes the drug. The study was terminated, but results may g…
Phase 1 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New drug batoclimab aims to ease muscle weakness in myasthenia gravis
Disease control Stopped earlyThis phase 3 trial tests batoclimab, a drug that blocks certain antibodies, in 240 adults with generalized myasthenia gravis (gMG). The study measures if batoclimab improves daily activities and muscle strength compared to a placebo. Participants receive injections weekly or bi-w…
Phase 3 • Sponsor: Immunovant Sciences GmbH • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New inhaled therapy targets mucus in asthma and COPD – but trial halted early
Disease control Stopped earlyThis early-phase trial tested an inhaled drug called ARO-MUC5AC in healthy volunteers and people with asthma or COPD. The goal was to see if it is safe and how it affects lung function by targeting mucus production. The study was terminated early, so we have less information than…
Phase 1/2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New schizophrenia drug goes Head-to-Head with standard antipsychotics in Long-Term trial
Disease control Stopped earlyResearchers are testing an experimental drug called LY2140023 in people with schizophrenia who have already completed a short-term trial of the same drug. The study compares LY2140023 to standard antipsychotic medications like olanzapine, aripiprazole, risperidone, and quetiapine…
Phase 2/3 • Sponsor: Denovo Biopharma LLC • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Tiny doses of avastin tested against laser for preemie eye disease
Disease control Stopped earlyThis study tested a low dose of the drug bevacizumab (Avastin) against standard laser treatment for retinopathy of prematurity, an eye disease that can blind premature infants. Sixteen babies with severe disease were enrolled. The goal was to see if the drug could control the dis…
Phase 3 • Sponsor: Jaeb Center for Health Research • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New inhaled therapy aims to save ventilator patients from viral pneumonia
Disease control Stopped earlyThis study tests an inhaled medicine called SNG001 in patients with severe viral pneumonia who need a breathing machine. The goal is to see if it safely helps clear the virus faster and lowers the risk of death. About 550 adults, mostly over 50 or with weakened immune systems, wi…
Phase 2 • Sponsor: Synairgen Research Ltd. • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New bladder cancer drug delivered directly into bladder shows early promise
Disease control Stopped earlyThis early-phase trial tested enfortumab vedotin, a drug placed directly into the bladder via a catheter, in 37 people with a type of bladder cancer that did not respond to standard BCG therapy. The main goals were to check safety and side effects, and to see if the drug could he…
Phase 1 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Five-Year safety check for experimental schizophrenia drug
Disease control Stopped earlyResearchers are studying the long-term safety of pomaglumetad methionil, an experimental drug taken by mouth, in adults with schizophrenia. About 129 participants receive the drug and are monitored for up to five years. The study tracks movement side effects, weight, blood sugar,…
Phase 3 • Sponsor: Denovo Biopharma LLC • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New depression drug tested for long-term safety in 1,000 patients
Disease control Stopped earlyThis study looks at the long-term safety and effectiveness of an experimental drug called NMRA-335140 for people with major depressive disorder. About 1,000 adults who completed earlier studies of this drug will take it for 52 weeks. Researchers will track side effects and change…
Phase 3 • Sponsor: Neumora Therapeutics, Inc. • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New drug combo aims to keep advanced breast cancer in check
Disease control Stopped earlyThis study tested whether a combination of olaparib (a targeted therapy) and pembrolizumab (an immunotherapy) works better than standard chemotherapy plus pembrolizumab for people with advanced triple-negative breast cancer that initially responded to chemo-immunotherapy. The tri…
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New drug cocktail shows promise in lung cancer battle
Disease control Stopped earlyThis phase 3 trial tested a new immunotherapy combination (pembrolizumab plus vibostolimab) with chemotherapy against the standard pembrolizumab-plus-chemotherapy for people with advanced non-small cell lung cancer. The study enrolled 739 participants who had not received prior t…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Can a heart rate drug keep heart failure patients out of the hospital?
Disease control Stopped earlyResearchers are testing whether starting ivabradine when heart failure patients leave an observation unit safely lowers heart rate and reduces the chance of returning to the hospital or emergency room. The trial enrolls adults with reduced ejection fraction heart failure who are …
Phase 4 • Sponsor: Phillip Levy • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Slower magnesium drip may help sickest patients hold onto the mineral
Disease control Stopped earlyCritically ill patients often have low magnesium, which can lead to heart rhythm problems and other complications. When magnesium is given through an IV, the body keeps only about half of it. Researchers are testing whether giving the same dose over 8 hours instead of 4 hours hel…
Sponsor: CAMC Health System • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Can an immune booster make chemo hit melanoma harder?
Disease control Stopped earlyResearchers are testing an experimental immunotherapy called ALT-801 alongside the chemotherapy drug cisplatin in people with metastatic melanoma that cannot be cured with surgery. The trial enrolls about 22 participants who have not received prior chemotherapy for their melanoma…
Phase 1/2 • Sponsor: Altor BioScience • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New immune cell therapy aims to prevent leukemia return after transplant
Disease control Stopped earlyThis early-phase trial tests a new cell therapy called BSB-1001 in 38 adults with high-risk blood cancers (AML, ALL, or MDS) who are getting a stem cell transplant. BSB-1001 is made from donor immune cells that are modified to attack a specific marker on cancer cells. The goal is…
Phase 1/2 • Sponsor: BlueSphere Bio, Inc • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New hope for High-Risk melanoma: combo therapy aims to prevent recurrence
Disease control Stopped earlyThis study tested whether adding vibostolimab to the standard immunotherapy pembrolizumab can better prevent melanoma from returning after surgery. About 1,600 people with high-risk stage II to IV melanoma took part. The goal was to see if the combination keeps cancer away longer…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Can a Once-Daily pill target Hard-to-Treat lung cancer?
Disease control Stopped earlyResearchers are testing an experimental daily capsule called AP-L1898 in adults with locally advanced or metastatic non-small cell lung cancer that cannot be treated with chemoradiotherapy. The study enrolls people whose cancer has worsened after standard treatment and whose tumo…
Phase 1/2 • Sponsor: Suzhou Junjing BioSciences Co., Ltd. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Promising targeted therapy for tough breast cancer hits roadblock
Disease control Stopped earlyThis study tested whether adding the drug alpelisib to standard chemotherapy (nab-paclitaxel) could help people with advanced triple negative breast cancer that has specific genetic changes (PIK3CA mutation or PTEN loss). The trial enrolled 137 participants but was stopped early.…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Could a monthly shot cut heart failure deaths? major trial underway
Disease control Stopped earlyThis study tests whether a monthly injection called ziltivekimab can reduce heart failure-related deaths, hospitalizations, and urgent visits in people with heart failure and signs of inflammation. About 5,600 participants will receive either the drug or a placebo for up to 4 yea…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New targeted combo shows promise for tough stomach cancer
Disease control Stopped earlyThis clinical trial is testing whether adding a targeted drug called bemarituzumab to standard chemotherapy and immunotherapy (nivolumab) helps people with advanced stomach or gastroesophageal junction cancer live longer. The study includes 515 adults whose tumors overexpress a p…
Phase 3 • Sponsor: Amgen • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Two common heart drugs face off in race to steady a racing heart
Disease control Stopped earlyResearchers compare two standard drugs, diltiazem and metoprolol, for controlling rapid heart rate in people who arrive at the emergency department with atrial fibrillation or atrial flutter. Adults with a heart rate of 100 beats per minute or higher are randomly assigned to rece…
Phase 4 • Sponsor: CAMC Health System • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Spinal injection drug targets genetic cause of ALS and dementia
Disease control Stopped earlyResearchers are testing repeated doses of an experimental drug called WVE-004 in adults who have ALS, frontotemporal dementia, or both, linked to a mutation in the C9orf72 gene. Participants receive the drug by spinal injection every 12 weeks for up to 96 weeks. The study tracks …
Phase 1/2 • Sponsor: Wave Life Sciences USA, Inc. • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New cancer drug GEN1057 tested in early trial – but study stopped early
Disease control Stopped earlyThis early-stage trial tested a new antibody drug called GEN1057 in 23 people with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check safety and see how the drug behaves in the body. The study was terminated early, so results ar…
Phase 1 • Sponsor: Genmab • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can a lung drug stop transplant rejection? new trial tests Alpha-1 antitrypsin for GVHD
Disease control Stopped earlyThis study tested whether a drug called alpha-1 antitrypsin (AAT) can prevent graft-versus-host disease (GVHD) in people receiving stem cell transplants for blood cancers. GVHD occurs when donor immune cells attack the patient's body. The trial enrolled 222 participants and compa…
Phase 2/3 • Sponsor: CSL Behring • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Experimental drug auxora tested in critical COVID-19 lung patients
Disease control Stopped earlyThis small Phase 2 trial tested an experimental drug called Auxora in 10 patients with critical COVID-19 pneumonia who were on ventilators. The goal was to see how the drug affected immune cells in the lungs and to check its safety. The study was terminated early, so results are …
Phase 2 • Sponsor: CalciMedica, Inc. • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can a plastic meniscus implant keep knees Pain-Free for years?
Disease control Stopped earlyThis registry study follows people who receive the NUsurface meniscus implant, a device designed to replace a damaged meniscus in the knee. Researchers track pain and knee function over time using standard scores like KOOS and WOMET. The goal is to see how well the implant works …
Sponsor: Phoenix Kinetics • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
A targeted drug takes aim at a Hard-to-Treat stomach cancer
Disease control Stopped earlyResearchers are testing an experimental drug called MRG003 in adults with advanced gastric or gastroesophageal junction cancer that has spread or cannot be removed by surgery. The trial enrolls people whose tumors test positive for EGFR and negative for HER2, a combination that l…
Phase 2 • Sponsor: Lepu Biopharma Co., Ltd. • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can an oral drug calm inflamed muscles in myositis?
Disease control Stopped earlyResearchers are testing an experimental oral drug called enpatoran in adults with dermatomyositis and polymyositis, two rare muscle-weakening diseases. Participants receive enpatoran or a placebo twice daily for up to 24 weeks while continuing their standard care. The trial measu…
Phase 2 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can a Melatonin-Like pill slow Alzheimer's memory loss?
Disease control Stopped earlyResearchers are testing whether piromelatine 20 mg, a tablet that acts on melatonin and serotonin receptors, can slow cognitive decline in people aged 60 to 85 with mild dementia from Alzheimer's disease. The study enrolls 216 participants who do not carry a specific genetic vari…
Phase 2/3 • Sponsor: Neurim Pharmaceuticals Ltd. • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New antibody combo shows promise in early cancer trial
Disease control Stopped earlyThis trial tests a new antibody called acasunlimab, alone or with other cancer drugs, in people with advanced solid tumors that have not responded to standard treatments. The study has two parts: first to find safe doses, then to see how well those doses work. About 429 participa…
Phase 1/2 • Sponsor: Genmab • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can stem cells boost brain surgery for epilepsy?
Disease control Stopped earlyThis early study tests whether delivering stem cells directly into the brain during deep brain stimulation (DBS) surgery is safe and feasible for people with drug-resistant epilepsy. One adult participant will receive a single dose of stem cells in the thalamus, a brain region in…
Early phase 1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Zapping ovaries: could a quick procedure replace daily pills for PCOS infertility?
Disease control Stopped earlyThis study tests a device that uses heat to ablate (destroy) a small part of the ovary in women with polycystic ovary syndrome (PCOS) who have trouble getting pregnant. The goal is to restore ovulation without needing daily medication. About 195 women will be randomly assigned to…
Sponsor: May Health • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a drug duo outsmart a common cancer mutation?
Disease control Stopped earlyThis early-stage trial tests whether combining two drugs, INCB099280 and adagrasib, is safe and tolerable for adults with advanced solid tumors that carry a specific genetic change called KRAS G12C. The study enrolls people whose cancer has spread or is locally advanced and who h…
Phase 1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a bone drug extend life in advanced lung cancer?
Disease control Stopped earlyThis phase III trial tests whether adding denosumab, a drug often used for bone health, to standard chemotherapy helps people with stage IV non-small cell lung cancer live longer. About 595 adults with advanced disease will receive either chemotherapy alone or chemotherapy plus d…
Phase 3 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can AI and peer support close the opioid treatment gap?
Disease control Stopped earlyThis trial tests whether an AI-driven texting tool, combined with support from peer recovery coaches, can help Black and Latinx people who use opioids start buprenorphine treatment in primary care. Participants are enrolled from emergency departments and receive text messages wit…
Sponsor: Friends Research Institute, Inc. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a new drug tame seizures in two severe epilepsy syndromes?
Disease control Stopped earlyThis phase 3 trial tests whether soticlestat can reduce seizures in people with Dravet syndrome or Lennox-Gastaut syndrome who have already used fenfluramine. Participants take soticlestat as tablets or mini-tablets, and researchers measure changes in seizure frequency over the f…
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Seizure drug safety trial halted early for dravet and LGS patients
Disease control Stopped earlyThis study looked at the long-term safety of soticlestat when added to standard seizure medicines for people with Dravet syndrome or Lennox-Gastaut syndrome. It included 352 children and adults who had already been in earlier studies. The trial was terminated early, so results ar…
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a Two-Drug combo outsmart resistant breast and ovarian cancers?
Disease control Stopped earlyResearchers are testing whether combining ribociclib and belinostat can help people with metastatic triple-negative breast cancer or recurrent ovarian cancer. The trial starts by finding the safest dose of the drug pair, then expands to see how well it works in breast cancer pati…
Phase 1 • Sponsor: University of Utah • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Experimental lung cancer drug MGY825 tested in early trial
Disease control Stopped earlyThis early-phase study tested an investigational drug called MGY825 in 41 adults with advanced non-small cell lung cancer that has specific genetic changes (NFE2L2/KEAP1/CUL3 mutations). The main goal was to check the drug's safety and find the right dose. The study was terminate…
Phase 1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New drug shows promise for Tough-to-Treat seizures in kids
Disease control Stopped earlyThis study looked at the long-term safety of soticlestat, an experimental drug, in children and adults with severe forms of epilepsy like Dravet syndrome and Lennox-Gastaut syndrome. Participants took soticlestat twice a day along with their usual seizure medicines. The study was…
Phase 2 • Sponsor: Takeda • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
CRISPR zaps HPV in cervical lesions: first human test begins
Disease control Stopped earlyThis early study tests a new CRISPR gene therapy (BD114) in 12 women with high-grade cervical lesions caused by HPV-16. The therapy is injected directly into the lesion to disable the virus's cancer-causing genes. The main goals are to check safety and see if the lesions clear up…
Early phase 1 • Sponsor: Shanghai BDgene Co., Ltd. • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a Triple-Drug cocktail outsmart Treatment-Resistant colorectal cancer?
Disease control Stopped earlyThis phase 2 trial is testing whether adding an experimental drug called evorpacept to two existing cancer drugs (cetuximab and pembrolizumab) can shrink tumors in people with a specific type of advanced colorectal cancer that has not responded to prior treatments. The study enro…
Phase 2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New combo therapy shows promise in early sarcoma trial
Disease control Stopped earlyThis study tests a new drug (ADI-PEG 20) combined with chemotherapy and radiation before surgery for soft tissue sarcoma. The goal is to find the safest dose and see how well it shrinks tumors. Only 6 patients with intermediate or high-grade sarcoma of the trunk or limbs are taki…
Phase 1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Promising combo therapy for incurable liver cancer shows potential in phase 3 trial
Disease control Stopped earlyThis study tested whether adding two drugs (lenvatinib and pembrolizumab) to a standard liver cancer treatment called TACE helps people with liver cancer that cannot be removed by surgery. About 479 participants received either the drug combo plus TACE or TACE alone. The goal was…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New combo therapy aims to ease strain on heart in rare lung condition
Disease control Stopped earlyThis study tests whether combining two medications (Riociguat and Macitentan) with a balloon procedure to open blocked lung arteries can improve heart function in people with chronic thromboembolic pulmonary hypertension (CTEPH). The trial enrolls 15 adults who cannot have surger…
Phase 3 • Sponsor: Dr Sudarshan Rajagopal • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Kava drink tested to help smokers cut down and lower cancer risk
Disease control Stopped earlyThis study tests whether a daily kava drink can help active smokers who don't plan to quit reduce their smoking and lower their risk of lung cancer. Twenty adult smokers will take kava daily for several months. Researchers will check how well participants stick with the regimen, …
Phase 2 • Sponsor: University of Florida • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New pill aims to boost red blood cells in MDS patients
Disease control Stopped earlyThis phase 2 trial tested a daily pill called etavopivat in 17 adults with very low, low, or intermediate risk MDS who had anemia. The goal was to see if the drug could improve red blood cell counts and reduce the need for transfusions. The study was terminated early, so the full…
Phase 2 • Sponsor: Forma Therapeutics, Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a cell therapy shrink Hard-to-Treat lung tumors?
Disease control Stopped earlyThis early-stage trial tests an experimental cell therapy called GAIA-102 in people with advanced or relapsed non-small cell lung cancer. Researchers give GAIA-102 alone or with the immunotherapy drug pembrolizumab to see if the combination is safe and can shrink tumors. The stud…
Phase 1/2 • Sponsor: GAIA BioMedicine Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New combo aims to boost immune attack on HPV-Driven head and neck cancer
Disease control Stopped earlyThis Phase 3 trial tests whether adding an experimental immunotherapy called PDS0101 to the standard drug pembrolizumab helps people with advanced HPV16-positive head and neck cancer live longer. About 252 participants will receive either the combination or pembrolizumab alone. T…
Phase 3 • Sponsor: PDS Biotechnology Corp. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can texts and peers help trans women beat HIV? trial cut short
Disease control Stopped earlyThis study aimed to find the best way to help transgender women living with HIV reach undetectable viral levels. Participants received either text messages, help from a peer health navigator, or both. The trial was ended early, so results are limited.
Sponsor: Friends Research Institute, Inc. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a shorter treatment hold off small HER2-Positive breast cancers?
Disease control Stopped earlyThis phase 2 trial tests whether a 12-week course of docetaxel plus trastuzumab after surgery can keep small (≤1 cm), node-negative HER2-positive breast cancer from returning. Women who have completed radical surgery for this type of cancer receive the two drugs every three weeks…
Phase 2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New drug combo targets Hard-to-Treat cancers
Disease control Stopped earlyThis early-phase study tests an experimental drug called INCB177054, given alone or with another drug (retifanlimab), in people with advanced or metastatic solid tumors that have not responded to standard treatments. The main goals are to check safety and find the right dose. Abo…
Phase 1/2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New drug switch may control lung cancer longer in High-Risk patients
Disease control Stopped earlyThis study looked at whether switching from the immunotherapy durvalumab to the targeted drug sotorasib can better control locally advanced non-small cell lung cancer in patients with a KRAS G12C mutation and signs of remaining cancer (minimal residual disease). Ten participants …
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Stool test could replace endoscopy for h. pylori treatment decisions
Disease control Stopped earlyThis study tested whether a simple stool test can guide doctors in choosing the right antibiotics for H. pylori infections, avoiding the need for an invasive stomach camera procedure. The test detects the bacteria and checks for antibiotic resistance, aiming to improve cure rates…
Sponsor: Poitiers University Hospital • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Experimental cell therapy takes aim at Hard-to-Treat pancreatic cancer
Disease control Stopped earlyThis early-phase trial tests a personalized cell therapy called TCR-T cells, engineered to recognize and attack cancer cells with a specific KRAS mutation. Up to 18 adults with advanced pancreatic cancer who have exhausted standard treatments will receive a single infusion of the…
Early phase 1 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Immunotherapy drug shows promise for tough bladder cancer cases
Disease control Stopped earlyThis phase II trial tested the immunotherapy drug pembrolizumab (Keytruda) alone or with another agent in 296 people with high-risk non-muscle-invasive bladder cancer that did not respond to standard BCG therapy. Participants received the drug intravenously every three weeks. The…
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New drug aimed at Kidney-Lung crisis shows promise in trial
Disease control Stopped earlyThis study tests an experimental drug called Auxora in 150 adults with acute kidney injury and breathing failure. Patients receive either Auxora or a placebo daily for five days. The goal is to see if Auxora helps patients survive, breathe without a machine, and avoid kidney dial…
Phase 2 • Sponsor: CalciMedica, Inc. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Experimental CAR-T therapy takes aim at Hard-to-Treat scleroderma
Disease control Stopped earlyThis early-phase trial is testing a new treatment called KYV-101 for people with systemic sclerosis, a disease where the immune system attacks the body, causing skin and organ damage. The therapy uses a patient's own modified immune cells to target and destroy certain B cells tha…
Phase 1/2 • Sponsor: Kyverna Therapeutics • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Could CAR-T cells tame tough lupus kidney disease?
Disease control Stopped earlyThis early-phase trial is testing a new treatment called KYV-101, which uses a patient's own modified immune cells (CAR-T cells) to target and destroy faulty B cells that drive lupus kidney inflammation. The study involves 6 adults with lupus nephritis that hasn't responded to st…
Phase 1/2 • Sponsor: Kyverna Therapeutics • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a daily pill help people with type 2 diabetes shed weight?
Disease control Stopped earlyThis phase 2 trial tests whether LY3549492, an oral tablet, helps adults who are overweight or obese and have type 2 diabetes lose weight. Participants receive either LY3549492 or a placebo for about 11 months. Researchers measure changes in body weight and the percentage of peop…
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Could diabetes pills replace insulin shots in hospitals?
Disease control Stopped earlyThis study compares continuing oral diabetes medications (like metformin) versus switching to insulin in hospitalized adults with type 2 diabetes. About 255 participants will be randomly assigned to either stay on their usual pills or receive insulin injections. The goal is to se…
Phase 4 • Sponsor: Emory University • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a drug cocktail make immunotherapy work better for Hard-to-Treat breast cancer?
Disease control Stopped earlyThis early-phase trial tests whether adding a combination of rintatolimod, celecoxib, and interferon alpha-2b can enhance the effectiveness of pembrolizumab, an immunotherapy drug, in people with metastatic or unresectable triple-negative breast cancer. The combination aims to mo…
Phase 1/2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Experimental cancer drug BGB-3245 studied in early trial
Disease control Stopped earlyThis early-phase study tested an experimental drug called BGB-3245 (brimarafenib) in 109 people with advanced solid tumors that had not responded to standard treatments. The drug is designed to block certain proteins that help cancer grow. The main goals were to check safety, fin…
Phase 1 • Sponsor: MapKure, LLC • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Experimental drug aims to save Insulin-Making cells in newly diagnosed type 1 diabetes
Disease control Stopped earlyThis Phase 2 trial tested an oral drug called ladarixin in 141 people aged 14-45 recently diagnosed with type 1 diabetes. The goal was to see if ladarixin could preserve the body's ability to produce insulin by protecting beta cells. The study was terminated early, so while it ma…
Phase 2 • Sponsor: Dompé Farmaceutici S.p.A • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Radioactive drug targets Hard-to-Treat melanoma in early trial
Disease control Stopped earlyThis early-stage trial tests a radioactive drug called [225Ac]Ac-A9-3408 in 50 adults with melanoma that has spread or can't be removed by surgery. The main goals are to find a safe dose and check for side effects. Participants receive the drug every 6 weeks for up to 6 doses, an…
Phase 1 • Sponsor: Alpha-9 Oncology USA Inc. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Experimental CAR-T therapy takes on Hard-to-Treat lupus nephritis
Disease control Stopped earlyThis early-phase trial is testing a personalized cell therapy called KYV-101 for people with lupus nephritis that hasn't responded to standard treatments. The therapy uses a patient's own immune cells, modified to target and destroy faulty B cells that drive the disease. Only 2 p…
Phase 1/2 • Sponsor: Kyverna Therapeutics • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Which eczema drug wins? a Head-to-Head test aims to find out
Disease control Stopped earlyThis trial compares two approved eczema drugs, upadacitinib and dupilumab, in people with moderate-to-severe atopic dermatitis. Researchers will measure how well each drug clears the skin and improves quality of life, including itch and sleep. The study aims to confirm earlier fi…
Sponsor: Technische Universität Dresden • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can an antiviral drug protect hearing in infants with congenital CMV?
Disease control Stopped earlyThis trial tests whether the antiviral drug valganciclovir can improve hearing and language outcomes in infants who have hearing loss due to congenital cytomegalovirus (CMV) infection. Infants aged 1 to 12 months with confirmed sensorineural hearing loss will receive either valga…
Phase 2 • Sponsor: Albert Park • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can a Two-Drug immunotherapy combo outperform standard care in Late-Stage colorectal cancer?
Disease control Stopped earlyThis clinical trial is testing whether a combination of two immunotherapy drugs, relatlimab and nivolumab, can help people with advanced colorectal cancer that has not responded to previous treatments. The study compares this combination to two standard chemotherapy options (rego…
Phase 3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Could a smart lung monitor outsmart asthma symptoms?
Disease control Stopped earlyThis trial tests whether a personalized asthma action plan guided by a home monitoring device—using Forced Oscillation Technique (FOT) to measure lung function—can improve asthma control better than the usual approach of adjusting medication based on how symptoms feel. People age…
Sponsor: Restech Srl • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Can a year of sunitinib delay kidney Cancer's return after lung surgery?
Disease control Stopped earlyThis phase 2 trial investigates whether taking the drug sunitinib for one year after surgical removal of lung metastases can improve relapse-free survival in patients with clear cell kidney cancer. Participants are randomly assigned to receive either sunitinib or a placebo follow…
Phase 2 • Sponsor: Association of Urologic Oncology (AUO) • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Can a less invasive valve replacement tame a failing aortic valve?
Disease control Stopped earlyThis study is a patient registry that collects information on people with severe aortic stenosis or aortic regurgitation who are treated with the Trilogy heart valve system, a device implanted via a catheter (TAVI) to replace the aortic valve without open-heart surgery. The goal …
Sponsor: JenaValve Technology, Inc. • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Can a new drug boost radiation's power against head and neck cancer in older patients?
Disease control Stopped earlyThis phase II trial is investigating whether adding the experimental drug xevinapant to standard radiation therapy can improve outcomes for adults aged 70 and older with locally advanced head and neck cancer. Participants are randomly assigned to receive either xevinapant or a pl…
Phase 2 • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Can a Lung-Blood-Pressure drug ease the strain of heart failure?
Disease control Stopped earlyThis trial tests whether riociguat, a drug that relaxes blood vessels in the lungs, can safely lower high blood pressure in the lungs of people who also have a weakened left heart chamber. Participants receive either riociguat or a placebo for 16 weeks, with doctors measuring lun…
Phase 2 • Sponsor: Bayer • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Which dialysis method works best for ICU kidney failure? a Head-to-Head test
Disease control Stopped earlyThis trial compares two ways of filtering blood in critically ill patients with severe acute kidney injury: intermittent hemodialysis (done in sessions) and continuous renal replacement therapy (done non-stop). The goal is to see if the intermittent method is just as good as the …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Could a One-Time X-Ray calm the deadly lung inflammation of severe COVID-19?
Disease control Stopped earlyThis phase II trial tests whether a single, ultra-low dose of radiation to both lungs can reduce the dangerous inflammation caused by COVID-19 pneumonia in critically ill patients who need a ventilator. The treatment, a one-time 80 cGy X-ray session, aims to calm the immune syste…
Phase 2 • Sponsor: Ohio State University • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Could a seizure drug curb alcohol withdrawal in trauma wards?
Disease control Stopped earlyThis trial tests whether valproate, a medication used for epilepsy, can help prevent or ease alcohol withdrawal symptoms in heavy drinkers admitted to trauma care. Participants receive standard treatment with lorazepam (a benzodiazepine) as needed, and some also get valproate. Th…
Phase 4 • Sponsor: CAMC Health System • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Can light therapy dry out a swollen retina?
Disease control Stopped earlyThis pilot study tests whether shining near-infrared light on the eye can reduce macular edema—swelling in the central retina—caused by a retinal vein occlusion. Six participants with this condition will receive 12 light treatments over about five weeks. The main goal is to see i…
Sponsor: University of Sydney • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Could a daily pill stop hereditary angioedema attacks?
Disease control Stopped earlyThis trial tests whether an experimental oral medication, deucrictibant, can reduce the number of swelling attacks in people with hereditary angioedema (HAE) types I and II. Participants take either a low or high dose of the drug or a placebo for 12 weeks, and then may continue o…
Phase 2 • Sponsor: Pharvaris Netherlands B.V. • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Can an organic compound tame COVID-19 in High-Risk patients?
Disease control Stopped earlyThis trial is testing an organic compound called NP-101 in adults with mild-to-moderate COVID-19 who are at high risk of severe illness. The study aims to find the safest and most effective dose, and to see whether NP-101 can help patients recover faster and reduce the amount of …
Phase 2 • Sponsor: Novatek Pharmaceuticals • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a new drug shield lungs from COVID-19's worst damage?
Disease control Stopped earlyThis trial tests whether an experimental drug called BIO101 can prevent severe breathing problems in hospitalized adults with COVID-19 pneumonia. Participants receive either BIO101 or a placebo for 28 days, and researchers track who develops respiratory failure, needs high-flow o…
Phase 2/3 • Sponsor: Biophytis • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can a Blood-Cleansing combo tame deadly lung Flare-Ups?
Disease control Stopped earlyThis trial tests whether a combination of plasma exchange, rituximab, and intravenous immunoglobulins can improve survival in people hospitalized in intensive care with a severe acute exacerbation of idiopathic pulmonary fibrosis (IPF). IPF is a progressive lung disease, and thes…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can a daily pill shrink the spleen in myelofibrosis?
Disease control Stopped earlyThis phase 3 trial is testing an experimental oral drug, SAR302503, in people with a rare bone marrow disorder called myelofibrosis who have an enlarged spleen. Participants are randomly assigned to receive one of two doses of the drug or a placebo. The main goal is to see if the…
Phase 3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Stem cell infusion may help severely ill COVID-19 patients breathe
Disease control Stopped earlyThis trial tests whether an experimental stem cell therapy called MultiStem can help people with moderate to severe acute respiratory distress syndrome (ARDS) caused by infections like COVID-19. ARDS is a serious lung condition that often requires a breathing tube and ventilator.…
Phase 2/3 • Sponsor: Healios K.K. • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a single stem cell infusion rewire the brain after stroke?
Disease control Stopped earlyThis phase 3 trial is testing whether a single infusion of MultiStem, an experimental stem cell product, can improve recovery in adults who have had a moderate-to-severe ischemic stroke within the past 18 to 36 hours. The study compares the stem cell treatment against a placebo t…
Phase 3 • Sponsor: Healios K.K. • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a targeted pill outperform chemo for bile duct cancer?
Disease control Stopped earlyThis trial is testing whether the targeted drug pemigatinib can slow or shrink a specific type of bile duct cancer (cholangiocarcinoma) that has a genetic change called FGFR2 rearrangement and cannot be removed by surgery. Participants will receive either pemigatinib as a daily p…
Phase 3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Virtual cues on a treadmill: a new hope for Parkinson's falls?
Disease control Stopped earlyThis trial tests whether adding augmented reality (AR) to treadmill training can help people with Parkinson's disease who have trouble walking and are at risk of falling. Participants will be randomly assigned to one of three groups: treadmill training with AR, treadmill training…
Sponsor: Klinik Valens • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Quitting before the knife: which Stop-Smoking aid works best for cancer patients?
Disease control Stopped earlyThis trial explores whether adding counseling, cognitive behavioural therapy, or hypnotherapy to nicotine replacement therapy can help cancer patients quit smoking before their surgery. The study includes adults with breast, digestive, gynecologic cancer, or melanoma who smoke da…
Sponsor: Institut Cancerologie de l'Ouest • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can a fluid from amniotic cells ease ankle arthritis pain?
Disease control Stopped earlyThis study tests whether a single injection of Axolotl Ambient, a fluid rich in growth factors derived from human amniotic cells, can reduce pain and improve function in people with ankle osteoarthritis. Participants will be randomly assigned to receive either the investigational…
Phase 1/2 • Sponsor: Axolotl Biologix • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Could a cholesterol drug and a bile acid pill help reverse liver scarring?
Disease control Stopped earlyThis pilot study tests whether simvastatin (a cholesterol-lowering drug) and ursodeoxycholic acid (a bile acid medication), taken alone or together for six months, can improve markers of liver fibrosis in adults with advanced liver scarring after viral hepatitis has been controll…
Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can a simple inhaled combo keep pneumonia patients off ventilators?
Disease control Stopped earlyThis phase 3 trial tests whether an inhaled combination of budesonide (a corticosteroid) and formoterol (a bronchodilator) can prevent acute respiratory failure in hospitalized adults with pneumonia and low blood oxygen levels. Participants receive either the active treatment or …
Phase 3 • Sponsor: Stanford University • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Could a different way of pedaling rebuild muscles after severe COVID-19?
Disease control Stopped earlyThis study tests whether a specific type of exercise, called eccentric exercise, can help people recover muscle strength and walking ability after a severe COVID-19 infection. Participants, aged 18 to 80, will be randomly assigned to either eccentric or standard concentric exerci…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Can a clotting boost make surgery safer for hemophilia patients?
Disease control Stopped earlyThis trial tests whether a medication called eptacog beta can safely prevent excessive bleeding in people with hemophilia A or B who have inhibitors and need major surgery. Participants receive the drug during and after their operation, and doctors measure how well bleeding is co…
Phase 3 • Sponsor: Laboratoire français de Fractionnement et de Biotechnologies • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Simple work advice may cut sick leave days, trial suggests
Disease control Stopped earlyThis trial tests whether a short vocational advice program helps people on sick leave return to work sooner. Adults who have been off work for at least two weeks due to health issues receive support from a trained worker to identify barriers and plan their return. The study compa…
Sponsor: Keele University • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Can an immune booster help chemotherapy fight metastatic breast cancer?
Disease control Stopped earlyThis trial tests whether adding an experimental immunotherapy called eftilagimod alpha to standard chemotherapy (paclitaxel) can help people with HER2-negative metastatic breast cancer live longer. The study first finds the best dose of eftilagimod alpha, then compares the combin…
Phase 2/3 • Sponsor: Immutep S.A.S. • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
A common diabetes drug may protect against hormone therapy's metabolic side effects
Disease control Stopped earlyThis phase 3 trial tests whether metformin, a standard diabetes medication, can prevent or reverse metabolic syndrome in men with prostate cancer who are starting androgen deprivation therapy (ADT). Metabolic syndrome—a cluster of conditions like high blood sugar, high blood pres…
Phase 3 • Sponsor: Canadian Urologic Oncology Group • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Can two drugs together tackle tough lung cancer?
Disease control Stopped earlyThis trial is testing whether combining two drugs—glumetinib and toripalimab—can help people with advanced non-small cell lung cancer that has not responded to or is no longer controlled by standard treatments. The study is enrolling adults whose cancer has a specific marker (PD-…
Phase 1/2 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Can a better antidote stop opioid overdoses faster?
Disease control Stopped earlyThis study investigates how effectively two opioid antidotes—naloxone (given as a nasal spray or injection) and nalmefene (given as an injection)—can reverse dangerous breathing problems caused by strong opioids like fentanyl. The trial includes both healthy volunteers and people…
Phase 1 • Sponsor: Leiden University Medical Center • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
A common supplement may shield bones in kidney disease — a trial puts it to the test
Disease control Stopped earlyThis pilot trial investigates whether potassium citrate can improve bone quality and strength in adults and children with chronic kidney disease. Participants take either potassium citrate or a placebo for six months, along with blood and urine tests and advanced bone scans. The …
Phase 2/3 • Sponsor: Albert Einstein College of Medicine • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Spinal cord stimulator may calm the 'fight or flight' system in chronic pain
Disease control Stopped earlyThis study investigates whether a spinal cord stimulator (SCS) alters the sympathetic nervous system — the body's fight-or-flight response — in people with Complex Regional Pain Syndrome (CRPS). Ten adults with CRPS will have their nerve activity, heart rate, and blood pressure m…
Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Can a once-weekly antibiotic help people with opioid use disorder beat serious infections at home?
Disease control Stopped earlyThis trial tests whether a weekly IV antibiotic called oritavancin, given alongside medication for opioid use disorder, can help people finish treatment for serious infections like bloodstream or bone infections without needing to stay in a nursing facility. The study enrolls adu…
Phase 4 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Could a lung cancer drug designed for one mutation work for another?
Disease control Stopped earlyThis phase II trial tests whether alectinib, a drug typically used for ALK-positive lung cancer, can shrink tumors or control disease in people with advanced non-small cell lung cancer that has a RET gene rearrangement and has progressed after prior treatment. Participants take a…
Phase 2 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Double hormone blockade may tackle Hard-to-Treat breast cancer
Disease control Stopped earlyThis trial tests a combination of two drugs, elacestrant and onapristone, in people with a specific type of advanced or metastatic breast cancer that is fueled by the hormones estrogen and progesterone. The goal is to see if blocking both hormone signals at once is safe and can s…
Phase 1/2 • Sponsor: Context Therapeutics Inc. • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Iron showdown: IV vs. pills for heart failure fatigue
Disease control Stopped earlyThis trial tests whether intravenous (IV) iron or oral iron pills work better for adults with congestive heart failure who also have low iron levels. Participants are randomly assigned to receive either a one-time IV infusion of ferric carboxymaltose (with a possible repeat dose)…
Phase 4 • Sponsor: Syed Hamza Mufarrih • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Could a quick quiz end millions of unnecessary penicillin allergies?
Disease control Stopped earlyThis study tests whether a short questionnaire can identify hospitalized patients who were incorrectly labeled as allergic to penicillin. Those deemed low-risk receive a supervised dose of amoxicillin to confirm they can tolerate it. If they do, the allergy label is removed from …
Early phase 1 • Sponsor: Geisinger Clinic • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Diabetes drug metformin could boost myeloma treatment
Disease control Stopped earlyThis phase 2 trial tests whether adding metformin — a common diabetes medication — to high-dose dexamethasone can improve outcomes for people with multiple myeloma that has returned or stopped responding to prior treatments. The study enrolls adults over 18 who have failed at lea…
Phase 2 • Sponsor: University of Campinas, Brazil • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Brain training: behavioral therapy may rewire social circuits in autistic toddlers
Disease control Stopped earlyThis study investigates whether a 10-week behavioral intervention called JASPER can improve early communication skills and alter brain activity in toddlers and preschoolers with autism. Participants aged 18 to 59 months receive twice-weekly sessions focused on joint attention and…
Sponsor: Boston University Charles River Campus • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New hope for myelofibrosis patients who stop responding to standard therapy
Disease control Stopped earlyThis phase 2 trial tests an experimental drug called SAR302503 in people with myelofibrosis who have already been treated with ruxolitinib. The main goal is to see if the drug can shrink the spleen by at least 35% after six months of daily oral capsules. The study also tracks whe…
Phase 2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Pre-surgery boot camp aims to cut complications in pancreatic cancer patients
Disease control Stopped earlyThis study tests a 4-week prehabilitation program combining exercise, nutritional supplements, and psychological support for patients with sarcopenia (muscle loss) who are about to have pancreatic cancer surgery. The goal is to see if this program reduces serious complications li…
Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Genetic clues could personalize breast cancer treatment
Disease control Stopped earlyThis study looks at genetic changes in postmenopausal women with a common type of advanced breast cancer (HR+ HER2-). Participants first receive ribociclib plus letrozole; those with a specific mutation (PIK3CA) may later switch to alpelisib plus fulvestrant. The goal is to track…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Can virtual coaching close the autism care gap for black toddlers?
Disease control Stopped earlyThis trial tests whether a telehealth-based family navigation program helps Black toddlers under age 4 start autism-specific intervention faster after diagnosis. Families in the program receive up to four virtual sessions with a trained navigator who helps them find and enroll in…
Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Could a CO2-Removal device save lives in severe COPD attacks?
Disease control Stopped earlyThis trial investigates whether adding a device that removes carbon dioxide from the blood (ECCO2R) to standard care improves survival in people with very severe flare-ups of chronic obstructive pulmonary disease (COPD). The study includes patients at high risk of needing a breat…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
AI speech coach boosts Kids' articulation in hybrid therapy trial
Disease control Stopped earlyThis study tests whether adding an AI speech therapist, named Jessica, to traditional speech therapy helps children with speech sound disorders improve their articulation more than standard therapy alone. Over 8 weeks, children aged 5 to 17 receive weekly sessions with a speech-l…
Sponsor: Syracuse University • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Iron infusions may boost gut healing in celiac disease
Disease control Stopped earlyThis trial investigates whether adding intravenous iron to standard oral iron supplements can help heal intestinal damage in people with celiac disease who have iron deficiency and gut atrophy. Participants receive either intravenous iron infusions plus oral iron, or oral iron al…
Phase 4 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Radiation and immunotherapy join forces against hard-to-treat liver cancer
Disease control Stopped earlyThis trial tests whether adding a precise, internal radiation treatment (166Holmium microspheres) to standard immunotherapy (atezolizumab and bevacizumab) can shrink liver tumors that cannot be surgically removed. About 10 adults with unresectable hepatocellular carcinoma will re…
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New drug aims to help lungs and heart work better during exercise
Disease control Stopped earlyThis phase 3 trial tests whether ralinepag, an oral medication, can improve exercise capacity in people with pulmonary arterial hypertension (PAH) who have recently started PAH therapy. Participants take ralinepag or a placebo for 28 weeks, and their peak oxygen consumption durin…
Phase 3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Could earlier testing for pregnancy diabetes prevent complications?
Disease control Stopped earlyThis trial investigates whether screening for gestational diabetes earlier in pregnancy (at 18-20 weeks instead of the usual 24-28 weeks) and providing prompt lifestyle advice and medication if needed can reduce complications such as large babies, C-sections, and high blood press…
Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New daily pill aims to tame Crohn's Flare-Ups
Disease control Stopped earlyThis trial investigates whether an oral medication called etrasimod can help people with moderate to severe Crohn's disease who have not responded well to other treatments. Participants take either etrasimod or a placebo daily for up to several years. The study measures improveme…
Phase 2/3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could less be more? shorter antibiotic course after appendix surgery put to the test
Disease control Stopped earlyThis trial compares two approaches to antibiotic use after appendix removal surgery: a restrictive course (none or up to 24 hours) versus a liberal course (24 hours to 4 days). The goal is to see if the shorter course is just as safe and effective, while reducing side effects and…
Phase 4 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Placenta cells tested as COVID fighter – but trial stopped early
Disease control Stopped earlyThis early-phase trial tested a new therapy called CYNK-001, which uses natural killer cells from the placenta to fight COVID-19. It enrolled only 7 adults with moderate COVID-19. The study was terminated early, so we have limited information on safety and effectiveness.
Phase 1/2 • Sponsor: Celularity Incorporated • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New biologic drug brazikumab tested for Crohn's – trial cut short
Disease control Stopped earlyThis study tested brazikumab, an experimental biologic drug, in 89 adults with moderate-to-severe Crohn's disease. Participants received either brazikumab, a placebo, or an active comparator (Humira) to see if the drug could improve symptoms and heal the gut lining. The trial was…
Phase 2/3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New drug shows promise for Long-Term control of ulcerative colitis
Disease control Stopped earlyThis study looks at the long-term safety of brazikumab, a drug given as a shot every 4 weeks, for people with moderate to severe ulcerative colitis. Participants had already taken part in an earlier study of brazikumab. The goal is to see if the drug remains safe over a longer pe…
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Heart failure fluid removal device trial halted early
Disease control Stopped earlyThis study compared a device called Aquadex, which filters excess fluid from the blood, to standard IV diuretics in 167 hospitalized heart failure patients with fluid overload. The goal was to see which method better prevented heart failure events like rehospitalization. However,…
Sponsor: Nuwellis, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Immunotherapy combo for liver cancer shows early promise but trial halted
Disease control Stopped earlyThis phase 2 trial tested the immunotherapy drug nivolumab (Opdivo) given before and after a procedure called electroporation for people with advanced hepatocellular carcinoma (liver cancer) that could still be treated with curative intent. The study aimed to see if adding nivolu…
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Experimental combo for tough leukemia hits early snag
Disease control Stopped earlyThis early-stage trial tested a combination of two targeted drugs—tagraxofusp-erzs and gemtuzumab ozogamicin—in 7 patients with acute myeloid leukemia that had come back or not responded to treatment. The goal was to find a safe dose and see if the combination could control the d…
Phase 1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Experimental blood thinner tested in heart attack emergency
Disease control Stopped earlyThis study tested an intravenous antiplatelet drug called PRT060128 in 70 people having a severe heart attack (STEMI). The goal was to see if giving the drug before emergency artery-opening treatment improved blood flow and was safe. The trial was terminated early, so the full re…
Phase 2 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Which oxygen strategy saves more lives? large trial puts three methods to the test
Disease control Stopped earlyThis trial tests whether high-flow nasal cannula oxygen or noninvasive ventilation works better than standard oxygen therapy for ICU patients with acute respiratory failure. About 1,470 adults will be randomly assigned to one of the three methods. The main goal is to see which ap…
Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Breast cancer drug showdown: which CDK4/6 inhibitor works best?
Disease control Stopped earlyThis phase 3 trial aimed to compare two drugs, ribociclib and palbociclib, in people with a specific type of advanced breast cancer (HR+/HER2- with HER2-enriched features). Participants received one of the drugs combined with hormone therapy. The goal was to see which combination…
Phase 3 • Sponsor: SOLTI Breast Cancer Research Group • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a common antibiotic ease severe wheezing in young children?
Disease control Stopped earlyThis study investigates whether a 5-day course of oral azithromycin can reduce wheezing severity in preschool children (18 months to under 5 years) who come to the emergency department with a severe wheezing episode. Children are randomly assigned to receive either azithromycin o…
Phase 3 • Sponsor: University of Arizona • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Experimental achondroplasia drug trial halted early
Disease control Stopped earlyThis study tested an experimental drug called SAR442501 in children with achondroplasia, a common form of dwarfism. The goal was to see if the drug was safe and could improve growth. However, the trial was stopped early after enrolling only 16 children, so we have very little inf…
Phase 2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug brazikumab aims to tame ulcerative colitis Flare-Ups
Disease control Stopped earlyThis phase 2 trial tested brazikumab in 242 adults with moderate-to-severe ulcerative colitis. Participants received either brazikumab or a placebo intravenously and then as injections over 54 weeks. The goal was to see if the drug could improve symptoms and heal the colon lining…
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Experimental heart valve device tested in just one patient — study halted
Disease control Stopped earlyThis early study tested a new device called the Cardiovalve Transfemoral Mitral Valve System in just one person with severe mitral regurgitation who was too high-risk for surgery. The device is inserted through a vein in the leg to replace the faulty mitral valve without open-hea…
Sponsor: Cardiovalve Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Phone calls from nurses aim to tame high blood pressure in women
Disease control Stopped earlyThis study tested whether a 6-month program of nurse-led phone calls could help women with uncontrolled high blood pressure take their medication as prescribed. The program included 7 phone calls to address barriers to medication adherence. Only 14 women enrolled before the study…
Sponsor: Mme Edith DAUCHY • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could a common laxative soothe gut inflammation in cystic fibrosis?
Disease control Stopped earlyThis phase 2 trial investigates whether polyethylene glycol (a laxative) can reduce intestinal inflammation in children with cystic fibrosis. The study includes children aged 4 to 17 with cystic fibrosis and pancreatic insufficiency who have elevated fecal calprotectin (a marker …
Phase 2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New oral pill aims to fight RSV in adults
Disease control Stopped earlyThis study tests an oral drug called AK0529 (Ziresovir) in adults aged 18 to 75 with respiratory syncytial virus (RSV) infection. Participants receive either the drug or a placebo, and researchers measure how well symptoms improve and track any side effects. The goal is to see if…
Phase 2 • Sponsor: Shanghai Ark Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Can IBD patients safely stretch their infusion schedule? new study tests two strategies
Disease control Stopped earlyThis study looks at people with inflammatory bowel disease (Crohn's disease or ulcerative colitis) who are in deep remission. It compares two methods for gradually increasing the time between infliximab infusions: one based on symptoms and one based on drug levels in the blood. T…
Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Personalized interferon therapy aims to tame kidney disease without weakening defenses
Disease control Stopped earlyThis phase 2 trial investigates whether a personalized course of peginterferon alfa-2a can control membranous nephropathy, an autoimmune kidney disease. The treatment targets the Th17 inflammatory pathway, which is linked to a higher risk of relapse. Participants receive injectio…
Phase 2 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug aims to free severe asthma patients from daily steroids
Disease control Stopped earlyThis Phase 3 trial tests whether tezepelumab, an injectable biologic, can help adults with severe asthma reduce their daily dose of oral corticosteroids while still keeping their asthma under control. Participants receive either tezepelumab or a placebo for 28 weeks, and doctors …
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Experimental bone putty for spinal surgery falls short in early trial
Disease control Stopped earlyThis study tested a special bone graft material (MatriBONE mixed with the patient's own bone marrow) for spinal fusion surgery in people with painful degenerative back problems. The goal was to see how well the bones fused together after 12 months. However, the trial was stopped …
Phase 2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a smartphone and pedometer help people get fitter before bariatric surgery?
Disease control Stopped earlyThis trial investigates whether a remote digital support program, including a connected pedometer and online coaching, can help people aged 30–50 who are scheduled for bariatric surgery become more physically active in the months before their operation. Participants use a digital…
Sponsor: Centre Hospitalier Intercommunal Creteil • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a glucose monitor boost diabetes education for newly diagnosed patients?
Disease control Stopped earlyThis study tested whether using a Freestyle Libre 2 continuous glucose monitor for 28 days, along with standard therapeutic education, helps people recently diagnosed with type 2 diabetes improve their blood sugar control. The trial enrolled 27 adults diagnosed within the past ye…
Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Tooth-Related sinusitis study halted early – results uncertain
Disease control Stopped earlyThis study looked at whether treating the dental cause of chronic maxillary sinusitis with dental procedures and medication could resolve symptoms. Only 16 patients were enrolled before the study was terminated. The main goal was to see if symptoms disappeared and pus cleared fro…
Sponsor: Centre Hospitalier Intercommunal Creteil • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could ditching heparin during heart valve repair cut bleeding risks?
Disease control Stopped earlyThis trial tests whether performing balloon aortic valvuloplasty without the blood thinner heparin reduces serious bleeding and blood vessel complications. About 94 adults with severe, symptomatic aortic stenosis will be randomly assigned to receive either heparin or a placebo du…
Phase 4 • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
CBD shows promise for alcohol use disorder in early trial
Disease control Stopped earlyThis phase 2 trial tested whether cannabidiol (CBD), a non-psychoactive compound from cannabis, could help people with alcohol use disorder reduce their drinking. The study also looked at whether CBD could protect the brain and liver from alcohol's harmful effects. Only 10 people…
Phase 2 • Sponsor: Hôpital le Vinatier • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Placenta power: could donor cells heal diabetic foot wounds?
Disease control Stopped earlyThis study tests whether injections of cells from donated human placentas can help heal foot ulcers in people with diabetes. The trial includes patients with and without peripheral artery disease, a common complication that slows healing. Participants receive either the cell trea…
Phase 2 • Sponsor: Celularity Incorporated • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New proton therapy aims to save eyes from removal in large melanoma cases
Disease control Stopped earlyThis study tested two different proton therapy schedules for people with large choroidal melanomas (eye cancer) that would normally require removal of the eye. The goal was to see if a gentler radiation schedule could control the tumor and avoid severe side effects, allowing pati…
Sponsor: Centre Antoine Lacassagne • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Gum graft showdown: synthetic vs. natural tissue in recession repair
Disease control Stopped earlyThis study tested whether a synthetic gum graft (Mucogain matrix) could be a good alternative to the standard connective tissue graft for treating receding gums. The goal was to see if the synthetic option covers the exposed tooth root just as well, but with less pain and fewer c…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Could collapsing a lung during heart surgery improve recovery?
Disease control Stopped earlyThis study tests whether using a special tube (EZ-Blocker) to collapse one lung during heart bypass surgery can reduce fluid buildup and the need for chest drains. The trial includes adults having planned coronary artery bypass surgery that uses the internal thoracic artery. The …
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Could a blood pressure cuff boost stroke recovery? trial tests the idea
Disease control Stopped earlyThis study tested whether repeatedly inflating and deflating a blood pressure cuff on the arm (remote ischemic conditioning) could improve recovery in 458 people who had a severe stroke caused by a blocked artery in the brain. The goal was to see if this simple, non-drug treatmen…
Sponsor: The First Affiliated Hospital of University of Science and Technology of China • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Glaucoma supplement trial fizzles: MEMOPTIC study halted early
Disease control Stopped earlyThis study tested whether a daily tablet called MEMOPTIC (containing citicoline, magnesium, and Ginkgo biloba) could help preserve vision in people with open-angle glaucoma when added to their usual eye-pressure-lowering treatments. The trial planned to follow 15 patients for two…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Eye drop gel shows promise for skin graft healing, but trial stalls
Disease control Stopped earlyThis study tested whether applying 0.25% timolol gel (a beta-blocker eye drop used for glaucoma) to skin grafts could improve healing and appearance after skin cancer surgery. Researchers planned to enroll 82 patients but stopped early with only 10 participants. The goal was to s…
Phase 2/3 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New hope for myelofibrosis patients who failed standard therapy?
Disease control Stopped earlyThis study tested a drug called selinexor in 17 people with a rare bone marrow cancer (myelofibrosis) that did not respond to or could not tolerate standard JAK inhibitor treatments. The main goal was to see if the drug could shrink an enlarged spleen by at least 35%. The trial w…
Phase 2 • Sponsor: University of Utah • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Could a common chemo drug boost the benefits of palliative radiation for advanced cancer?
Disease control Stopped earlyThis phase 3 trial tests whether adding the chemotherapy drug carboplatin to standard palliative radiotherapy helps control tumor growth and reduce pain better than radiotherapy alone. The study includes adults with advanced lung or head and neck cancer who need palliative radiat…
Phase 3 • Sponsor: Institut Cancerologie de l'Ouest • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
HIV drug showdown: which strategy works best for new patients?
Disease control Stopped earlyThis study compared two HIV treatment approaches in people who had never taken HIV drugs before. One group started with a three-drug combo for 16 weeks, then switched to a two-drug combo. The other group took a two-drug combo from the start. The goal was to see if the first appro…
Phase 3 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Heart drug fails to prove benefit for lung failure patients in early-stop trial
Disease control Stopped earlyThis study tested whether giving the heart medication metoprolol through a vein could help people with severe lung failure (ARDS) in the ICU. The goal was to see if it helped them breathe without a machine for more days. However, the trial was stopped early and only 14 people too…
Phase 3 • Sponsor: Consorcio Centro de Investigación Biomédica en Red (CIBER) • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Promising heart rhythm fix trial halted early – only 7 patients tested
Disease control Stopped earlyThis study aimed to see if combining surgical and catheter ablation (hybrid therapy) works better than standard catheter ablation alone for people with persistent atrial fibrillation. The trial was terminated after enrolling only 7 participants, so no meaningful conclusions can b…
Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Lung cancer gene therapy trial halted early
Disease control Stopped earlyThis early-stage trial tested a new gene therapy called quaratusugene ozeplasmid (Reqorsa) combined with the immunotherapy pembrolizumab (Keytruda) in people with advanced non-small cell lung cancer who had already received treatment. The goal was to see if the combination was sa…
Phase 1 • Sponsor: Genprex, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Less invasive heart attack care for the elderly put to the test
Disease control Stopped earlyThis study looked at two ways to manage older patients (80+) who had a mild type of heart attack (NSTEMI). One group got routine angiography (an invasive look at the heart's arteries), while the other group first had a non-invasive imaging test (SPECT or stress echo) and only got…
Sponsor: University Hospital, Grenoble • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could aspirin or ibuprofen help beat TB faster?
Disease control Stopped earlyThis study tested whether adding aspirin or ibuprofen to standard tuberculosis (TB) treatment helps patients recover more quickly. It included 426 adults with drug-sensitive or drug-resistant TB. The trial was terminated early, so the results are not conclusive.
Phase 2 • Sponsor: Fundació Institut Germans Trias i Pujol • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Heart drug may tame baby blood vessel growth
Disease control Stopped earlyThis study tested if the beta-blocker propranolol could control the growth of infantile hemangiomas (non-dangerous blood vessel growths) in babies under 4 months old. The trial was terminated early and only enrolled 14 infants. The goal was to measure changes in hemangioma thickn…
Phase 2/3 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Focused ultrasound trial for rare sarcoma halted early
Disease control Stopped earlyThis study tested whether focused ultrasound could partially destroy a rare soft-tissue cancer called undifferentiated pleomorphic sarcoma and boost the body's immune response. Only 5 people were enrolled before the trial was terminated. The main goal was to check safety and see …
Sponsor: Matthew Bucknor • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Heart drug trial halted early: MYK-224 studied for thick heart muscle
Disease control Stopped earlyThis study tested an experimental drug called MYK-224 in 18 adults with a type of heart disease that makes the heart muscle too thick and blocks blood flow. The goal was to see if the drug is safe and helps reduce symptoms. The trial was stopped early, so results are limited.
Phase 2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
HIV drug switch may boost heart health and trim body fat
Disease control Stopped earlyThis study looked at whether switching from a standard HIV drug combination to a different one (Delstrigo) could improve cholesterol, body fat, and blood sugar in people with HIV. The study planned to enroll 60 adults whose HIV was already well-controlled. Participants were rando…
Phase 4 • Sponsor: Chelsea and Westminster NHS Foundation Trust • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Can early speech therapy boost language in preterm babies?
Disease control Stopped earlyThis study tested an early speech therapy program for children born very prematurely or with severe growth restriction. The program involved 10 to 20 sessions with a trained speech therapist from 6 to 24 months of age. The goal was to see if it could reduce language and communica…
Sponsor: Centre Hospitalier Sud Francilien • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Heart drug study halted early: what we know
Disease control Stopped earlyThis study tested an experimental drug called CRD-4730 in people with a rare inherited heart rhythm disorder (CPVT) that can cause dangerous fast heartbeats. Seven adults received two different doses of the drug and a placebo to check safety and how the body processes it. The stu…
Phase 2 • Sponsor: Cardurion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Hospital hep c treatment aims to cure drug users
Disease control Stopped earlyThis study tested giving hepatitis C treatment to people who inject drugs while they were already in the hospital for other infections. The goal was to cure their hepatitis C and make sure they stayed connected to care afterward. The study was stopped early, but it included 21 pa…
Sponsor: Kirby Institute • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New drug combo tested for tough bile duct cancers
Disease control Stopped earlyThis study tested a new drug called LSTA1 added to standard treatment for people with advanced bile duct or gallbladder cancer. The goal was to see if the combination is safe and works better than standard treatment alone. The trial was stopped early, and results are not yet avai…
Phase 2 • Sponsor: Lisata Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Early trial of lenalidomide after transplant for myeloma stopped early
Disease control Stopped earlyThis phase 1 trial tested the safety of the drug lenalidomide as maintenance therapy after a reduced-intensity stem cell transplant for multiple myeloma. Only 13 people took part, and the study was terminated early. The goal was to see if lenalidomide could help prevent the cance…
Phase 1 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Mistletoe vs. chemo: bladder cancer trial halted early
Disease control Stopped earlyThis study aimed to see if a mistletoe extract placed directly into the bladder could delay cancer return better than standard chemotherapy in 174 people with early-stage bladder cancer. The trial was stopped early, so results are limited. The approach focuses on controlling the …
Phase 3 • Sponsor: Abnoba Gmbh • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Implantable pump could drain fluid for heart failure patients
Disease control Stopped earlyThis early study tested a device that is surgically placed in the belly to continuously remove extra fluid from the body. It was designed for people with advanced heart failure whose bodies no longer respond to water pills. Only 2 patients were enrolled before the study was stopp…
Sponsor: Paragate Medical LTD • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Tiny brain scanner takes on the big machine
Diagnosis Stopped earlyResearchers are testing NeuroLF, a small brain-only PET scanner, to see if it can produce brain images good enough for diagnosis. Participants who are already scheduled for a routine brain PET scan receive an extra scan on NeuroLF right after their standard scan, using the same r…
Sponsor: Positrigo AG • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
Bedside eye scans may reveal hidden blood flow problems in septic shock
Diagnosis Stopped earlySepsis and septic shock cause widespread inflammation and organ failure, and problems with the smallest blood vessels may drive worse outcomes. Researchers are testing whether a non-invasive eye imaging technique called optical coherence tomography angiography (OCTA) can detect t…
Sponsor: Hospital da Luz, Portugal • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
Breath-Tracking sensor aims to sharpen lung cancer scans
Diagnosis Stopped earlyResearchers are testing a breathing sensor called SPI that synchronizes PET/CT scans with a patient's breath. The goal is to see if this device can produce clearer images of lung tumors and nodules. Each participant undergoes a scan with both the SPI device and a standard breathi…
Sponsor: Institut Claudius Regaud • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
Microscope aims to spare breast cancer patients a second surgery
Diagnosis Stopped earlyResearchers are testing a nonlinear microscope (NLM) that images breast tissue during lumpectomy without the usual slide preparation. The goal is to see if the NLM can help surgeons find close or positive margins right away, so fewer patients need a second operation. The trial en…
Sponsor: Beth Israel Deaconess Medical Center • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
Glow-in-the-Dark dye could help surgeons spot hidden oral cancer cells
Diagnosis Stopped earlyThis study tested a dye called tozuleristide that makes oral cancer cells glow under special light during surgery. The goal was to help surgeons see and remove all cancer while sparing healthy tissue. The trial included 8 adults with oral cavity cancer or high-grade dysplasia. Th…
Phase 1/2 • Sponsor: University of Washington • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
Hospitals could screen every patient for hepatitis c
Diagnosis Stopped earlyResearchers at a French hospital are testing whether offering hepatitis C screening to all adult inpatients is practical and useful. The study enrolls adults admitted to the hospital who agree to a blood test. The team measures how many patients get screened, how many test positi…
Sponsor: Centre Hospitalier Intercommunal Creteil • Aim: Diagnosis
Last updated Sep 17, 2026 00:00 UTC
-
Can your phone spot eye cancer? app tested for retinoblastoma
Diagnosis Stopped earlyThis study tested a smartphone app called CRADLE that uses a photo to detect leukocoria (a white glow in the pupil), which can be a sign of retinoblastoma, cataracts, or glaucoma. Researchers planned to compare the app's accuracy to a standard eye exam in children with these cond…
Sponsor: St. Jude Children's Research Hospital • Aim: Diagnosis
Last updated Sep 17, 2026 00:00 UTC
-
One prick, three diseases: new rapid test under study
Diagnosis Stopped earlyThis study is testing a new medical device called MagIA IBC that uses a single drop of blood from a finger prick to screen for HIV, hepatitis B, and hepatitis C at the same time. Researchers will enroll 252 adults who are known or suspected to have one of these infections. The go…
Sponsor: MagIA Diagnostics • Aim: Diagnosis
Last updated Sep 13, 2026 00:00 UTC
-
New radioactive tracer could spot lung cancer mutations
Diagnosis Stopped earlyThis early-stage trial tests a radioactive imaging agent called [111In]-FPI-2107 in 12 Chinese adults with EGFR-mutant non-small cell lung cancer. The goal is to see if it is safe and can help detect tumors on SPECT scans. Participants receive the agent plus an unlabelled antibod…
Phase 1 • Sponsor: AstraZeneca • Aim: Diagnosis
Last updated Sep 13, 2026 00:00 UTC
-
Portable devices could take the guesswork out of eye pressure checks
Diagnosis Stopped earlyEye pressure is usually measured with a technique called Goldmann applanation tonometry, which doctors consider the gold standard but which depends on the examiner's skill and offers limited repeatability. Researchers at Duke University are testing automated versions of this meas…
Sponsor: Duke University • Aim: Diagnosis
Last updated Sep 13, 2026 00:00 UTC
-
Can less dye and less radiation still spot appendicitis?
Diagnosis Stopped earlyResearchers are testing a CT scan that uses less contrast dye and lower radiation to diagnose appendicitis in young adults. The study compares this low-dose approach against standard dosing to see if it still gives accurate results. Participants are emergency patients with suspec…
Sponsor: Bohyun Kim • Aim: Diagnosis
Last updated Sep 11, 2026 00:00 UTC
-
Blood test may spot hidden clots from central lines in critical care
Diagnosis Stopped earlyThis study tests whether a blood test called a thrombin generation assay can detect central line related thrombosis, a blood clot that forms around a central catheter, in critically ill patients. Researchers will compare clotting activity in ICU patients who develop these clots v…
Sponsor: Queen Mary Hospital, Hong Kong • Aim: Diagnosis
Last updated Sep 06, 2026 00:00 UTC
-
Can a sharper PET tracer light up hidden neuroendocrine tumors?
Diagnosis Stopped earlyThis trial tests an injected tracer called Gallium-68 HA-DOTATATE, which binds to somatostatin receptors found on most neuroendocrine tumors. Researchers want to see if a PET/CT or PET/MRI scan using this tracer is safe and accurately detects these tumors compared with standard C…
Phase 1/2 • Sponsor: AHS Cancer Control Alberta • Aim: Diagnosis
Last updated Sep 05, 2026 00:00 UTC
-
A finger-prick test that could outpace measles outbreaks
Diagnosis Stopped earlyResearchers in Senegal are testing a new rapid diagnostic test for measles that works with a drop of blood from a finger or a swab of oral fluid. The test is designed for use by health workers without lab training, aiming to confirm cases faster during outbreaks. The study will c…
Sponsor: Institut Pasteur de Dakar • Aim: Diagnosis
Last updated Sep 04, 2026 00:00 UTC
-
A simple blood test might spot sepsis risk before symptoms worsen
Diagnosis Stopped earlyThis study tests whether a standard blood test can help predict sepsis in adults arriving at the emergency department. The test measures a marker called monocyte distribution width (MDW), which reflects how varied certain white blood cells are. Researchers will compare MDW result…
Sponsor: Beckman Coulter, Inc. • Aim: Diagnosis
Last updated Sep 02, 2026 00:00 UTC
-
New bladder testing device under scrutiny in 180-Patient study
Diagnosis Stopped earlyThis study is testing the NXT Urodynamics System, a device used to measure how well the bladder stores and releases urine. Researchers want to confirm it is safe and works correctly in people with bladder problems like incontinence or overactive bladder. About 180 adults who need…
Sponsor: Laborie Medical Technologies Inc. • Aim: Diagnosis
Last updated Sep 02, 2026 00:00 UTC
-
A single blood draw to unmask hidden infections in immune-weakened patients?
Diagnosis Stopped earlyThis trial tests a new blood test that uses metagenomic sequencing to identify any infection-causing microbe in cancer patients who develop febrile neutropenia—a serious fever that occurs when their immune system is weakened by treatment. The test aims to find the culprit faster …
Sponsor: Poitiers University Hospital • Aim: Diagnosis
Last updated Aug 27, 2026 00:00 UTC
-
A simple breath test could spot mesothelioma years earlier
Diagnosis Stopped earlyThis study explores whether chemicals in a person's breath, called volatile organic compounds, can serve as early warning signs of pleural mesothelioma in people who have been exposed to asbestos. Researchers will also check if a blood marker, SMRP, adds to the breath test's accu…
Sponsor: Henry Ford Health System • Aim: Diagnosis
Last updated Aug 12, 2026 00:00 UTC
-
Can a new scale give voice to pain in the blind?
Diagnosis Stopped earlyThis study tests whether a new tool, the VISIODOL® scale, can help people with visual impairment communicate pain. Researchers will compare pain ratings from this scale with those from a standard numerical scale during heat-induced pain. The study includes healthy volunteers with…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Diagnosis
Last updated Aug 09, 2026 00:00 UTC
-
A Parent's smartphone video could be a new tool to screen kids for sleep apnea
Diagnosis Stopped earlyThis study tests whether a 10-minute video of a sleeping child, recorded by parents on a smartphone, can help identify obstructive sleep apnea. The video analysis will be compared with standard sleep monitoring and a clinical questionnaire in children aged 3 to 10 who snore. If t…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Diagnosis
Last updated Aug 08, 2026 00:03 UTC
-
AI reads eye photos to spot Diabetes-Related vision loss
Diagnosis Stopped earlyThis study tests whether an artificial intelligence program called NeoRetina can accurately detect diabetic retinopathy and diabetic macular edema from simple eye photographs. Researchers will compare the AI's analysis to standard exams by eye doctors. The goal is to see if this …
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Diagnosis
Last updated Jul 10, 2026 00:00 UTC
-
New blood test aims to catch live prostate cancer cells
Diagnosis Stopped earlyThis study tests a new blood test called EPIDROP that looks for live circulating tumor cells in men with metastatic prostate cancer. The test uses a special technique to isolate single cells and measure their activity. Researchers want to see if EPIDROP is as good as or better th…
Sponsor: University Hospital, Montpellier • Aim: Diagnosis
Last updated Jun 27, 2026 14:01 UTC
-
Super-Fine ultrasound could spare melanoma patients a second surgery
Diagnosis Stopped earlyThis trial investigates whether a new, ultra-high-frequency ultrasound device can accurately measure the depth of skin melanomas before surgery. Currently, doctors must remove the tumor, measure its depth under a microscope, and then often perform a second surgery to remove more …
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
New Light-Based test aims to catch deadly newborn gut disease early
Diagnosis Stopped earlyThis study looked at whether measuring oxygen levels in the brain and gut using a light-based device (NIRS) could help doctors diagnose necrotizing enterocolitis (NEC) earlier in newborns with symptoms like bloody stool or a swollen belly. The study planned to include 45 newborns…
Sponsor: University Hospital, Montpellier • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
New blood test could replace risky amniocentesis for genetic disorders
Diagnosis Stopped earlyThis study tested a new blood test that looks for fetal cells in the mother's blood to diagnose genetic diseases in the baby. It aimed to replace invasive tests like amniocentesis, which carry a small risk of miscarriage. The trial enrolled 18 pregnant women but was terminated ea…
Sponsor: University Hospital, Montpellier • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC
-
Triple imaging technique aims to sharpen prostate cancer detection
Diagnosis Stopped earlyThis study tested a new way to guide prostate biopsies by combining three imaging methods: a PET scan using a special tracer (fluorocholine), multiparametric MRI, and 3D ultrasound. The goal was to see if this triple approach could more accurately target suspicious areas in the p…
Sponsor: Lille Catholic University • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC
-
Tears may replace spinal taps for MS diagnosis
Diagnosis Stopped earlyThis study tests whether a tear sample can diagnose primary progressive multiple sclerosis (MS) as accurately as a spinal tap. Currently, doctors need to collect spinal fluid to confirm this type of MS, which is invasive and uncomfortable. Researchers will compare proteins in tea…
Sponsor: Lille Catholic University • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC
-
New heart artery measurements could sharpen diagnosis
Diagnosis Stopped earlyThis study tests new methods to measure pressure, blood flow, and blockage size in heart arteries. Researchers want to see if these measurements can better identify which blockages are serious enough to cause heart damage. The study involves people with known or suspected coronar…
Sponsor: University of Cincinnati • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC
-
New scan aims to spot brain bleeding after stroke – but study stalls
Diagnosis Stopped earlyThis study tested whether a cone beam CT scan, done right after a stroke procedure called thrombectomy, could tell the difference between a brain hemorrhage and harmless contrast dye buildup. Only 5 adults were enrolled before the study was stopped early. The goal was to see if t…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC
-
Pee test could replace pap smear for some women
Diagnosis Stopped earlyThis study tested whether offering a home urine test for human papillomavirus (HPV) could encourage more women to get screened for cervical cancer. The trial targeted women aged 30–65 in Brittany, France, who had not responded to an initial invitation for a Pap smear. Participant…
Sponsor: University Hospital, Brest • Aim: Diagnosis
Last updated Jun 27, 2026 13:05 UTC
-
Virtual reality could spot eye nerve damage earlier than flashlight test
Diagnosis Stopped earlyThis study tested whether a virtual reality headset combined with machine learning can measure pupil reactions more reliably than the standard flashlight test for Relative Afferent Pupillary Defect (RAPD). About 71 adults with and without known RAPD took part. Researchers compare…
Sponsor: The University of Texas Medical Branch, Galveston • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
New PET tracer aims to reveal hidden immune activity in tumors and arteries
Diagnosis Stopped earlyThis Phase II study tested a radioactive tracer called 68GaNOTA-Anti-MMR-VHH2 to see if it can light up certain immune cells (macrophages) on PET scans. The trial included 29 people with head and neck cancer, lymphoma, atherosclerosis, or sarcoidosis. The goal was to see if the t…
Phase 2 • Sponsor: Universitair Ziekenhuis Brussel • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
Ultrasound vs x-ray: a new way to spot lung issues in sick babies?
Diagnosis Stopped earlyThis study looked at whether chest ultrasound could be as good as chest X-ray for finding lung complications in infants under 2 years old with bronchiolitis. Only 19 babies were enrolled before the study was stopped early. The goal was to see if ultrasound, which uses no radiatio…
Sponsor: University Hospital, Toulouse • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
New screening method aims to catch lung cancer earlier in asbestos workers
Diagnosis Stopped earlyThis study looked at whether analyzing sputum (phlegm) with automated cytometry, combined with low-dose CT scans and blood tests, could better detect lung cancer in workers heavily exposed to asbestos. The goal was to reduce false positives and improve early diagnosis. The trial …
Phase 3 • Sponsor: University Hospital, Caen • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
Testosterone cream may stop repeat UTIs in older women
Prevention Stopped earlyThis study tests whether a vaginal testosterone cream can prevent repeat urinary tract infections (UTIs) in postmenopausal women aged 60-90 who have had at least three UTIs. Participants will apply the cream or a placebo for 9 months and be monitored for infections. The goal is t…
Phase 4 • Sponsor: Jefferson Drapkin • Aim: Prevention
Last updated Sep 19, 2026 00:00 UTC
-
Brain radiation for breast cancer: prevention study halted early
Prevention Stopped earlyThis study looked at whether giving radiation to the brain could prevent cancer from spreading there in people with HER2-positive breast cancer that had already spread to other organs. Participants were receiving trastuzumab (Herceptin) plus chemotherapy. The study was stopped ea…
Phase 3 • Sponsor: Centre Oscar Lambret • Aim: Prevention
Last updated Sep 19, 2026 00:00 UTC
-
Can a vegan diet shield police officers from heart disease?
Prevention Stopped earlyResearchers are testing whether a plant-based diet can improve heart health in police officers who are overweight or have type 2 diabetes. The trial enrolls 20 officers from the Washington, D.C. police department and randomly assigns them to either follow a vegan diet with weekly…
Sponsor: Physicians Committee for Responsible Medicine • Aim: Prevention
Last updated Sep 19, 2026 00:00 UTC
-
Can a Two-Week hormone course stop epilepsy before it starts?
Prevention Stopped earlyThis trial tests whether giving a low dose of the hormone ACTH to infants with early warning signs on their brain wave test (EEG) can prevent West syndrome, a severe form of epilepsy. Infants between 2 and 12 months old who show a specific pre-seizure brain pattern are treated wi…
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Prevention
Last updated Sep 11, 2026 00:00 UTC
-
Can a comic and newsletter program help families prevent childhood obesity?
Prevention Stopped earlyResearchers are testing a mobile health program that uses web-based comics for children and newsletters for parents to encourage healthier eating and lower obesity risk. The study enrolls 8- to 12-year-old Black and Latino children and a parent, who receive either the comic-and-n…
Sponsor: Tufts University • Aim: Prevention
Last updated Sep 11, 2026 00:00 UTC
-
New HIV prevention pill shows promise in large trial
Prevention Stopped earlyThis phase 3 study tested a daily pill called F/TAF (Descovy) to prevent HIV infection in nearly 5,400 men and transgender women who have sex with men and are at high risk. Participants took either F/TAF or the existing prevention drug Truvada. The goal was to see if F/TAF is as …
Phase 3 • Sponsor: Gilead Sciences • Aim: Prevention
Last updated Sep 10, 2026 00:00 UTC
-
Could a common painkiller stop breast cancer from returning?
Prevention Stopped earlyThis trial tests whether taking aspirin daily can prevent HER2-negative breast cancer from returning in people who have already had surgery, chemotherapy, or radiation. Participants have node-positive or high-risk node-negative breast cancer and are free of recurrence. Half recei…
Phase 3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Prevention
Last updated Sep 06, 2026 00:00 UTC
-
Breast cancer prevention study halted: tamoxifen pill vs. gel tested
Prevention Stopped earlyThis study aimed to see if a tamoxifen skin gel could work as well as the pill to lower breast cancer risk in women with certain high-risk breast conditions. The trial enrolled 65 women and compared short-term changes in breast tissue. However, the study was terminated early, so …
Phase 2 • Sponsor: Mayo Clinic • Aim: Prevention
Last updated Sep 03, 2026 00:00 UTC
-
Epilepsy drug may protect organs during heart surgery — trial tests the idea
Prevention Stopped earlyThis trial tests whether sodium valproate, a drug used for epilepsy, can reduce damage to the heart and kidneys in adults undergoing heart surgery with a heart-lung machine. Participants receive the drug for one to six weeks before their operation, and researchers measure organ i…
Phase 1/2 • Sponsor: University of Leicester • Aim: Prevention
Last updated Aug 19, 2026 00:00 UTC
-
Can a Pre-Surgery skin coating stop wound infections?
Prevention Stopped earlyThis trial tests whether applying a microbial sealant called Integuseal to the skin before leg bypass surgery can reduce postoperative wound infections. About 450 people scheduled for lower-limb arterial bypass procedures will be randomly assigned to receive the sealant or standa…
Sponsor: Rijnstate Hospital • Aim: Prevention
Last updated Aug 15, 2026 00:00 UTC
-
Could a Mother's Omega-3 supplement shield preterm Babies' lungs?
Prevention Stopped earlyThis trial tests whether giving mothers a DHA-rich omega-3 supplement after delivering very preterm (before 29 weeks) could improve their babies' chances of surviving without bronchopulmonary dysplasia, a chronic lung condition. Half the mothers receive DHA capsules, and half rec…
Phase 3 • Sponsor: CHU de Quebec-Universite Laval • Aim: Prevention
Last updated Aug 15, 2026 00:00 UTC
-
Tiny trial on preventive bladder sling halted early — no clear answers
Prevention Stopped earlyThis study looked at women with pelvic organ prolapse who also had hidden (occult) stress urinary incontinence — leakage that doesn't show up on standard tests. The goal was to see if placing a TOT sling during prolapse surgery could prevent incontinence from appearing later. The…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Prevention
Last updated Jun 28, 2026 00:00 UTC
-
Infection-Fighting stitches tested for C-Sections, but trial stopped early
Prevention Stopped earlyThis study tested whether using stitches coated with an antibacterial agent (triclosan) could reduce infections after cesarean delivery. Over 1,100 women were planned to take part, but the trial was stopped early. Because it was terminated, we cannot draw firm conclusions about w…
Phase 4 • Sponsor: The University of Texas Medical Branch, Galveston • Aim: Prevention
Last updated Jun 27, 2026 14:01 UTC
-
Heart drug mavacamten tested in Non-Obstructive HCM trial
Symptom relief Stopped earlyThis Phase 3 study tested the drug mavacamten in 580 adults with symptomatic non-obstructive hypertrophic cardiomyopathy, a heart muscle condition that makes it harder for the heart to pump blood. Participants received either mavacamten or a placebo. The study measured changes in…
Phase 3 • Sponsor: Bristol-Myers Squibb • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can exercise boost brain and body health during opioid treatment?
Symptom relief Stopped earlyResearchers are testing whether a 12-week exercise program can improve thinking skills, physical fitness, and quality of life for adults in opioid substitution therapy. Participants are randomly assigned to start exercise right away or after a 12-week wait. The study measures cha…
Sponsor: Haukeland University Hospital • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Gut bacteria supplement tested against chemo hair loss
Symptom relief Stopped earlyResearchers are testing a synbiotic formula called BLHK03 to see if it can reduce hair loss caused by chemotherapy in women with breast cancer. The trial includes 7 women with stage I to III breast cancer who are scheduled for chemotherapy with anthracycline or taxane drugs. Part…
Sponsor: GenieBiome Limited • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
New pill could ease neck dystonia symptoms
Symptom relief Stopped earlyThis study tests an experimental oral medication, MTR-601, for people with cervical dystonia, a condition causing painful neck muscle spasms and abnormal head posture. About 80 adults will receive either the drug or a placebo for 8 weeks to see if it safely reduces symptoms. The …
Phase 2 • Sponsor: Motric Bio • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Does mixing numbing agent into steroid shots ease hand pain?
Symptom relief Stopped earlyDoctors often treat trigger finger, de Quervain's tenosynovitis, and carpal tunnel syndrome with steroid injections. Some mix in a local anaesthetic to reduce pain after the shot, while others do not. This trial compares pain levels in adults who receive a steroid injection with …
Phase 3 • Sponsor: University Hospital Plymouth NHS Trust • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Three knee shots go Head-to-Head for lasting arthritis relief
Symptom relief Stopped earlyResearchers at Ohio State University are running a double-blind, randomized trial to compare three single-dose injections for knee osteoarthritis: Zilretta, Synvisc-One, and Monovisc. The study enrolls adults aged 25 to 85 with painful knee osteoarthritis that continues despite p…
Phase 4 • Sponsor: Ohio State University • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Precision brain radiation aimed at easing cancer bone pain
Symptom relief Stopped earlyThis study tested whether a single, highly focused dose of radiation to a tiny part of the brain (the pituitary gland) could help relieve severe, hard-to-treat bone pain caused by cancer that has spread. Only 5 people took part, and the study was stopped early. The goal was to se…
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can Brain-Training games rewire the mind to fight alcohol addiction?
Symptom relief Stopped earlyResearchers at the University of Florida are testing whether computerized cognitive training can help people with alcohol use disorder improve their memory, self-control, and thinking skills during inpatient treatment. Participants complete up to 12 sessions of adaptive brain-tra…
Sponsor: University of Florida • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Two strong painkillers go Head-to-Head in the ambulance
Symptom relief Stopped earlyParamedics in the Netherlands often treat severe pain after trauma with either fentanyl or esketamine, but no one knows if one works as well as the other or if a nasal spray works as well as an IV. The FORE-PAIN trial randomly assigns adults with acute traumatic pain to one of fo…
Phase 3 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Brain-Sensing headband tested to ease cancer Survivors' anxiety
Symptom relief Stopped earlyThis pilot study tests whether a wearable EEG headband (MUSE-S) that guides meditation can help breast cancer survivors who struggle with anxiety and insomnia. Twenty participants will use the headband at home, and researchers will track how often they use it and whether it impro…
Early phase 1 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
New obesity drug candidate enters first human tests
Symptom relief Stopped earlyThis early-stage study is testing an experimental drug called LY4064912 in 144 healthy volunteers and people with overweight or obesity. The main goal is to check safety and how the body handles the drug, not yet to prove it works for weight loss. Participants will receive either…
Phase 1 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Heat may boost numbing power of lidocaine for eye shots
Symptom relief Stopped earlyResearchers at the University of Missouri-Columbia are testing whether warming lidocaine to 98 F makes it work better than room-temperature lidocaine for numbing the eye before intravitreal injections. The study includes 100 people who receive these injections for various eye con…
Sponsor: University of Missouri-Columbia • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Could a High-Fat diet boost brain health in early Alzheimer's?
Symptom relief Stopped earlyThis study looks at whether a ketogenic diet (high-fat, low-carb) is practical and safe for people with early-stage Alzheimer's disease over one year. The diet may provide an alternative energy source for the brain and reduce inflammation. Researchers will track diet adherence, b…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Can a Quit-Smoking program built for transgender adults help them stop?
Symptom relief Stopped earlyTransgender and gender diverse adults smoke at higher rates than the general population, and stigma, discrimination, anxiety, and depression may make quitting harder. Researchers at Massachusetts General Hospital are adapting an existing smoking cessation program called QUIT, whi…
Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Can a flexible night splint ease heel pain as well as a rigid one?
Symptom relief Stopped earlyResearchers at Stanford University are comparing two types of night splints for people with plantar fasciitis, a common cause of heel pain. The trial tests whether a dynamic splint, which allows some foot movement, works as well as a static splint that holds the foot in one posit…
Sponsor: Stanford University • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Blue light tested as painkiller for broken ribs
Symptom relief Stopped earlyThis study tests whether shining bright blue light on adults with painful rib fractures can reduce pain and inflammation. 75 hospitalized patients will be randomly assigned to receive blue light, white light, or standard hospital lighting for 4 hours each morning for up to 3 days…
Sponsor: Rebecca E Kotcher, MD • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
WaterPik for your head? study tests scalp massager for flakes and hair loss
Symptom relief Stopped earlyThis study tested a WaterPik-like device to massage and clean the scalp in people with dandruff, seborrheic dermatitis, or hair loss. Only 2 people took part before the study was stopped early. The goal was to see if the device could reduce flaking and redness.
Sponsor: University of Minnesota • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
Can a breathing gadget calm anxious teens?
Symptom relief Stopped earlyThis study tests whether a biofeedback breathing system called Freespira can reduce anxiety and panic symptoms in young people aged 9 to 17. Over 8 weeks, one group uses the device while a control group waits. The goal is to see if the device helps lower anxiety scores on a stand…
Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Steroid-Free nausea control: new hope for chemo patients?
Symptom relief Stopped earlyThis study compared two standard drugs—olanzapine and dexamethasone—for preventing nausea and vomiting caused by chemotherapy. Researchers wanted to see if olanzapine could work as well as the steroid dexamethasone, potentially allowing patients to avoid steroid side effects. The…
Phase 4 • Sponsor: The Guthrie Clinic • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Migraine drug trial for kids halted early – what we know
Symptom relief Stopped earlyThis study aimed to see if lasmiditan, a migraine medicine, is safe and works for children aged 6 to 17. It planned to treat migraine attacks and measure pain relief. The trial was stopped early, so final results are limited, but it may still provide useful information about trea…
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
New antibody shots aim to stop itchy eyes from birch pollen
Symptom relief Stopped earlyThis study tests two experimental drugs (REGN5713 and REGN5715) given alone or together to reduce eye allergy symptoms caused by birch pollen. About 350 adults with birch pollen allergy will receive the drugs or a placebo and then be exposed to pollen in a controlled setting. The…
Phase 3 • Sponsor: Regeneron Pharmaceuticals • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
CBD shows promise for emotional health in HIV patients
Symptom relief Stopped earlyThis study tested whether synthetic cannabidiol (CBD) could help people living with HIV who have a condition called alexithymia, which makes it hard to recognize and describe emotions. Participants took either CBD or a placebo for 4 weeks. The goal was to see if CBD could improve…
Phase 2 • Sponsor: University of California, San Diego • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Fasting diet may ease immunotherapy side effects in cancer patients
Symptom relief Stopped earlyThis study tests whether a special low-calorie, plant-based diet that mimics fasting can reduce common side effects like rash, diarrhea, and fatigue in cancer patients receiving immunotherapy. Ten adults with advanced cancer will follow the diet and report their symptoms. The goa…
Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
Can High-Tech toothbrushes protect gums in scleroderma?
Symptom relief Stopped earlyThis trial tests whether using a sonic toothbrush and a water flosser improves gum health better than a standard manual toothbrush in people with systemic sclerosis, a rare disease that often affects the mouth. About 20 adults with the condition will be randomly assigned to one o…
Sponsor: University Hospital, Strasbourg, France • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
Can gentle electrical pulses reawaken hand movement after stroke?
Symptom relief Stopped earlyThis trial tests different settings of a gentle electrical stimulation device, placed on the skin of the affected arm, to see which ones best improve hand function in people who have had a stroke. Participants will receive varying durations and strengths of stimulation, and resea…
Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
Could exercise retrain the heart in long COVID?
Symptom relief Stopped earlyThis trial tests whether a structured cardiac rehabilitation program can improve exercise capacity and heart rate response in people with Long COVID. Participants have persistent symptoms and reduced exercise tolerance after a confirmed COVID-19 infection. The program includes pe…
Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
New program aims to break the Pain-Depression cycle in older women
Symptom relief Stopped earlyThis study tested a program called PRIME for older women with chronic pain and depression who also have physical disabilities. Nine women took part in nurse-led goal-setting visits and group therapy sessions focused on acceptance and commitment. The goal was to see if this combin…
Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Can a Once-Daily eye drop ease pain and swelling after cataract surgery?
Symptom relief Stopped earlyThis trial tests whether OCS-01, a dexamethasone eye drop, can reduce inflammation and pain after cataract surgery. About 117 adults scheduled for cataract removal will receive either the active drop or a placebo once daily. The study measures how well the drop clears eye inflamm…
Phase 3 • Sponsor: Oculis • Aim: Symptom relief
Last updated Aug 01, 2026 00:00 UTC
-
Virtual reality may calm colonoscopy jitters without drugs
Symptom relief Stopped earlyThis trial tests whether a combination of virtual reality and psychotherapy can help people undergoing colonoscopy without sedation feel less anxious and experience less pain. Participants will be randomly assigned to receive the VR-enhanced psychotherapy, a sham VR distraction, …
Sponsor: Grigore T. Popa University of Medicine and Pharmacy • Aim: Symptom relief
Last updated Aug 01, 2026 00:00 UTC
-
Sugar pills, no lies: could Open-Placebo ease teen depression?
Symptom relief Stopped earlyThis study tests whether placebo pills taken knowingly — called open-label placebo — can reduce depression symptoms in unmedicated teens aged 13–18 with mild to moderate depression. Participants take placebo pills for two weeks while researchers use brain scans to see if the trea…
Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
Can a synthetic cannabinoid calm agitation in frontotemporal dementia?
Symptom relief Stopped earlyThis phase 2 trial tests whether nabilone, a synthetic cannabinoid, can reduce agitation in people with frontotemporal dementia (FTD). Participants receive both nabilone and a placebo in random order to compare effects. The study includes adults with behavioral variant FTD or pri…
Phase 2 • Sponsor: Simon Ducharme, MD • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
Could emotional awareness therapy soothe mysterious body aches?
Symptom relief Stopped earlyThis pilot study tests whether a short-term group therapy called Emotional Awareness and Expression Therapy (EAET) can help people with persistent physical symptoms like pain or fatigue that have no clear medical cause. The therapy focuses on helping participants identify and exp…
Sponsor: Daniel Maroti • Aim: Symptom relief
Last updated Jul 29, 2026 00:00 UTC
-
Mindful walking may ease knee pain without pills
Symptom relief Stopped earlyThis study tests whether a mindful walking program can help people with knee osteoarthritis walk better and more often. Participants are randomly assigned to either a mindful walking group or a self-care education group, both meeting over 11 sessions in 6 months. The study focuse…
Sponsor: Boston University Charles River Campus • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
Virtual reality could cure stage fright in just one session
Symptom relief Stopped earlyThis study tests whether virtual reality (VR) can help young adults with public speaking anxiety. Participants receive either one or three sessions of VR exposure therapy, followed by a 4-week online program. The goal is to see if a single VR session works as well as multiple ses…
Sponsor: Vilnius University • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
Numbing ear drops could ease children's ear infection pain faster
Symptom relief Stopped earlyThis trial tests whether adding lidocaine ear drops to standard painkillers provides better ear pain relief for children aged 1–6 with acute otitis media. Half the children receive the ear drops plus usual care (oral painkillers, with or without antibiotics), while the other half…
Phase 3 • Sponsor: UMC Utrecht • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
Tiny incision, big relief? ultrasound procedure challenges carpal tunnel surgery
Symptom relief Stopped earlyThis study compared a new, minimally invasive ultrasound-guided procedure to standard surgery for carpal tunnel syndrome. The goal was to see if the new technique could provide similar relief with a smaller incision and faster recovery. Only 7 people were enrolled before the stud…
Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
Could skipping the chest tube after lung surgery cut pain and hospital time?
Symptom relief Stopped earlyThis trial investigates whether removing the chest tube during thoracoscopic lung surgery, instead of leaving it in place afterward, leads to less pain and faster recovery. Participants undergoing elective wedge resection are randomly assigned to have the tube removed during surg…
Sponsor: Rigshospitalet, Denmark • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Can osteopathy ease fibromyalgia pain?
Symptom relief Stopped earlyThis study tested whether osteopathic care (hands-on manipulation) can help reduce pain in people with fibromyalgia. 32 participants received osteopathic treatments over 8 months, with a follow-up 3 months later. The goal was to see if this approach could improve pain and quality…
Sponsor: University Hospital, Caen • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Multitasking rehab for stroke walkers: hype or help?
Symptom relief Stopped earlyThis study looked at whether practicing walking while doing other tasks (multitasking) helps people recovering from a stroke walk faster than just walking practice alone. It included 26 adults who had a stroke within the past 6 months and had trouble walking. The trial was stoppe…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Balloon treatment for sinusitis may offer faster recovery and less pain
Symptom relief Stopped earlyThis study compared a newer, less invasive procedure called balloon sinuplasty to standard surgery for people with frontal sinusitis that did not improve with medication. The balloon procedure uses a small catheter to open blocked sinus passages, aiming to reduce pain, bleeding, …
Sponsor: University Hospital, Strasbourg, France • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Simple needle puncture may replace scalpel for pilonidal abscesses
Symptom relief Stopped earlyThis study compared two ways to drain a pilonidal abscess: a simple needle puncture (aspiration) versus the standard incision. The goal was to see if puncture leads to faster healing, lower cost, and less time off work. Only 5 adults took part before the trial was stopped early, …
Sponsor: University Hospital, Angers • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Botox for groin pain? small study explores new treatment
Symptom relief Stopped earlyThis study tested whether injecting botulinum toxin A (Dysport) into the groin muscles could relieve chronic pain from adductor tendinopathy (pubalgia) in people who didn't get better with rest, anti-inflammatories, or physical therapy. Only 4 participants were enrolled before th…
Phase 2 • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Can a simple video ease the fear of breast cancer surgery?
Symptom relief Stopped earlyThis study investigates whether giving patients personalized, secure access to a web platform with an explanatory video about their upcoming breast cancer surgery can lower their anxiety. Participants are women with breast cancer scheduled for lumpectomy, oncoplasty, or mastectom…
Sponsor: University Hospital, Montpellier • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Nasal spray could replace needles for sickle cell pain emergencies
Symptom relief Stopped earlyThis study tested a nasal spray containing a strong painkiller (sufentanil) for adults with sickle cell disease experiencing a painful crisis. The goal was to see if it could provide faster relief than the standard gas mixture (EMONO) before giving morphine through an IV. The tri…
Phase 3 • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Could a nerve pain drug and exercise ease long COVID fatigue?
Symptom relief Stopped earlyThis study tests whether the drug pregabalin, alone or with a rehabilitation program, can reduce chronic fatigue in people with post-COVID syndrome. Participants are adults aged 18 to 65 who had COVID-19 at least six months ago and still feel very tired. The trial compares four g…
Phase 2 • Sponsor: National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Can a smartphone app slow ALS decline?
Symptom relief Stopped earlyThis study tested whether a digital platform (m-Rehab) could help people with ALS who use non-invasive ventilation. The platform included educational content, remote monitoring, and video consultations. The goal was to see if it could slow the loss of physical function and improv…
Sponsor: University Hospital, Montpellier • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Pain drug lyrica put to the test for rare limb condition – but trial stalls
Symptom relief Stopped earlyThis study tested whether adding pregabalin (Lyrica) to standard treatment could reduce pain and improve function in people with complex regional pain syndrome (CRPS) of the upper limb. Only 14 adults were enrolled before the trial was stopped early. The goal was to see if the dr…
Sponsor: McMaster University • Aim: Symptom relief
Last updated Jun 27, 2026 13:08 UTC
-
Robot suit aims to ease pain for kids with cerebral palsy
Symptom relief Stopped earlyThis study tested whether a motorized orthosis (Innowalk) that mimics walking is better tolerated by children with cerebral palsy than standard standing devices. The trial included 25 children aged 6-16 who had never walked. Researchers measured pain, muscle stiffness, and joint …
Sponsor: Lille Catholic University • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Parkinson's drug side effect targeted by antioxidant NAC – but trial stalls
Symptom relief Stopped earlyThis study tested whether N-acetylcysteine (NAC), an antioxidant, could help reduce impulse control disorders caused by Parkinson's medications. Only 14 people with mild-to-moderate symptoms were enrolled before the trial was stopped early. The goal was to see if 10 weeks of NAC …
Phase 3 • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
App aims to get breast cancer patients moving during chemo
Symptom relief Stopped earlyThis study tested a smartphone app called 'Bouge' to see if it could help women with non-metastatic breast cancer increase their daily steps while on weekly Taxol chemotherapy. The goal was to add 3,000 steps per day over 90 days. Only 23 people enrolled, and the trial was stoppe…
Sponsor: University Hospital, Brest • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Yoga for pain? tiny trial ends early
Symptom relief Stopped earlyThis study tested whether a six-week course of yoga, mindfulness, and breathing exercises could help people with chronic pain feel better and manage stress. Only 5 patients took part before the trial was stopped early. Because it was so small, we cannot say whether these techniqu…
Sponsor: McMaster University • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Heart hole closure for migraines? tiny study halted early
Symptom relief Stopped earlyThis study tested whether closing a small hole in the heart (called a PFO) with a device could reduce migraine headaches. It planned to compare the real procedure to a sham (fake) procedure in adults aged 18-55 with frequent migraines. However, the study was stopped early after e…
Sponsor: W.L.Gore & Associates • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
New pain block aims to cut opioid use after kidney surgery
Symptom relief Stopped earlyThis study looked at whether adding an ultrasound-guided ESP nerve block to standard pain medicine could reduce opioid use and improve pain control after laparoscopic kidney removal for cancer. Ten adults having keyhole kidney surgery were enrolled. The study was stopped early, s…
Sponsor: McMaster University • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Steroid combo fails to show benefit for UC flares
Symptom relief Stopped earlyThis study looked at whether adding high-dose steroid pulses to the usual oral steroid course could help people with moderate ulcerative colitis flares achieve remission without needing other treatments. The trial was terminated early and enrolled 75 adults with left-sided or ext…
Phase 4 • Sponsor: Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Botox injections may help stroke survivors move their arms better
Symptom relief Stopped earlyThis study observed 18 chronic stroke patients who received botulinum toxin injections into their elbow muscles as part of routine care. The goal was to see if the injections reduced muscle tightness (spasticity) and improved active arm extension. Researchers measured muscle acti…
Sponsor: University Hospital, Toulouse • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Ultrasound-Guided breathing support tested for chest injuries
Symptom relief Stopped earlyThis study tested whether using lung ultrasound to adjust ventilator pressure could improve oxygen levels in people with blunt chest trauma. Nineteen adults with rib fractures or lung bruises who needed breathing support were enrolled. The trial was terminated early, so the findi…
Sponsor: University Hospital, Montpellier • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Ear device aims to cut opioid use after liver transplant
Symptom relief Stopped earlyThis study tested a small device worn on the ear that uses mild electrical pulses to help control pain after a liver transplant. The goal was to see if it could reduce the need for strong painkillers like opioids. The study was stopped early and included 27 adults waiting for a l…
Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Exercise program for myeloma patients shows promise but study ends early
Symptom relief Stopped earlyThis study looked at whether a supervised exercise program could help improve quality of life and reduce fatigue in people under 65 with multiple myeloma who had a stem cell transplant. Participants were randomly assigned to either an exercise group or a control group. The study …
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Symptom relief
Last updated Jun 27, 2026 12:39 UTC
-
Can PET scans reveal hidden heart inflammation after a stroke?
Knowledge-focused Stopped earlyPeople who have a stroke face a much higher risk of heart problems in the following weeks, but researchers do not fully understand why. This study uses PET/MRI scans of the heart and blood tests for inflammatory markers to see whether inflammation develops in the heart after a st…
Sponsor: Luciano A. Sposato • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
ICU kidney injury: does the pattern predict lasting damage?
Knowledge-focused Stopped earlyResearchers are studying adults who spend more than a day in intensive care to understand how acute kidney injury affects kidney health months later. The study tracks the occurrence and duration of kidney injury episodes during the ICU stay and measures kidney function at 3 and 1…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Heart Disease's hidden toll: study tracks quality of life across mind, body, and spirit
Knowledge-focused Stopped earlyResearchers at the Cleveland Clinic are following 380 adults with hypertrophic cardiomyopathy, thoracic aortic dilatation, or radiation-induced heart disease. Participants complete a detailed survey at the start and again nine months later. The survey measures global, physical, e…
Sponsor: The Cleveland Clinic • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Why lung cancer patients lose weight: scientists measure the Body's fuel switch
Knowledge-focused Stopped earlyResearchers at Pennington Biomedical Research Center are studying how unintended weight loss affects the way the body burns fuel in people with advanced non-small-cell lung cancer. Participants eat a liquid mixed meal while researchers measure their breathing to see whether their…
Sponsor: Pennington Biomedical Research Center • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Can zapping the ear during a nap boost memory?
Knowledge-focused Stopped earlyResearchers at the University of California, San Francisco are studying whether stimulating the vagus nerve through the ear during a nap can improve memory. The trial enrolls healthy adults aged 18 to 64 who nap regularly. Participants receive either active stimulation or a sham …
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Does alcohol blunt the instinct to step in? study tests bystander behavior
Knowledge-focused Stopped earlyResearchers at the University of Colorado, Denver, are studying how alcohol intoxication affects a person's willingness to intervene as a bystander in a sexual violence scenario. They will recruit 153 young adults aged 21 to 30 who drink regularly. Participants are randomly assig…
Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Can a smart tampon predict your fertile days better than pee sticks?
Knowledge-focused Stopped earlyThis study compares a new at-home vaginal device (Kegg) that measures electrical changes in cervical mucus to standard methods like urine hormone strips and mucus checks. About 500 women aged 18-40 will use the device for three menstrual cycles. The goal is to see if the device c…
Sponsor: Lady Technologies Inc • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Why did women skip a breast cancer trial? COVID money woes may be key
Knowledge-focused Stopped earlyThis study looked at whether COVID-19 caused more financial hardship for Women of Color compared to other women who decided not to join a breast cancer screening trial. Researchers surveyed 14 women about job loss, income drops, and housing or food insecurity. The goal was to und…
Sponsor: Eastern Cooperative Oncology Group • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Pfizer mines insurance data to see if its vaccine stops long COVID
Knowledge-focused Stopped earlyThis study looks at anonymous health records from California and Louisiana to see if the Pfizer-BioNTech COVID-19 vaccine helps prevent post-COVID conditions (long COVID). Researchers will also track who gets vaccinated. The study includes adults with a COVID-19 diagnosis between…
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Brain fatigue after thyroid disease: immune system may be to blame
Knowledge-focused Stopped earlyThis study investigates why some people with Graves' disease continue to feel mentally fatigued even after their thyroid levels return to normal. Researchers will compare blood and spinal fluid from 180 participants—60 with mental fatigue, 60 without, and 60 healthy controls—to f…
Sponsor: Vastra Gotaland Region • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Can community storytelling boost breast cancer screening in rural areas?
Knowledge-focused Stopped earlyThis study tests whether community health forums called WE-CARE can help more rural and low-income women get screened for breast cancer and join clinical trials. The forums include educational sessions, survivor storytelling, and patient navigation to address barriers. Researcher…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Is RSV a hidden driver of severe COPD attacks?
Knowledge-focused Stopped earlyResearchers are studying adults with COPD who go to the emergency room or day hospital for sudden worsening of their breathing. The study checks how many of these patients test positive for respiratory syncytial virus (RSV) during the RSV season, from October to April. They compa…
Sponsor: Fundacio Privada Mon Clinic Barcelona • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Experimental immune drug tested in HPV cancers – but trial halted early
Knowledge-focused Stopped earlyThis very early trial tested a single dose of HB-201 in 10 people with HPV 16+ throat or cervical cancer. The goal was to see how the drug affects the immune system, not to treat the cancer. The study was terminated early, so results are limited.
Early phase 1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Can imagining future events and brain zaps ease pain and cravings?
Knowledge-focused Stopped earlyThis study looks at whether imagining positive future events (Episodic Future Thinking) and using low-intensity focused ultrasound on the brain can help people with both chronic pain and alcohol use disorder. Ten adults will try these interventions and report changes in pain, cra…
Sponsor: Kirstin M Gatchalian • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Scientists squeeze and release heart failure patients to uncover exercise secrets
Knowledge-focused Stopped earlyThis study looked at how applying positive or negative pressure around the body affects exercise in people with heart failure with preserved ejection fraction. 27 participants, including healthy volunteers and heart failure patients, were tested non-invasively and some invasively…
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Home infusions may help patients stick to treatment
Knowledge-focused Stopped earlyThis study looks at whether people with Fabry, Gaucher, or Hunter disease are more likely to continue their IV treatment when it's given at home versus at a hospital. Researchers will review existing data from 222 patients in Mexico. No new treatments are given; the goal is to un…
Sponsor: Takeda • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Mesh check: 7-Year study tracks prolapse repair success
Knowledge-focused Stopped earlyThis study looks at how well a specific mesh (GYNEMESH PS) works for women who had surgery to fix pelvic organ prolapse. About 100 women will be checked roughly 7 years after their surgery to see if the repair is still successful. The goal is to gather long-term information on th…
Sponsor: Ethicon, Inc. • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Swiss registry aims to map rare neuroendocrine tumors
Knowledge-focused Stopped earlyNeuroendocrine tumors of the gut and pancreas are rare and not well understood, which makes treatment decisions hard. The SwissNET registry collects health information from patients across Switzerland who have these tumors. Researchers will track tumor types, treatments used, and…
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Watching the Brain's blood supply as anesthesia takes hold
Knowledge-focused Stopped earlyResearchers observe how blood flow to the brain changes when adults receive general anesthesia for radiology procedures or orthopedic surgery. They use ultrasound, near-infrared light, and brain wave monitoring to measure blood flow velocity, oxygen levels, and brain activity at …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Brain imaging may reveal who benefits from depression therapy
Knowledge-focused Stopped earlyThis study looks at brain activity in 100 adults with major depression who are receiving a treatment called accelerated TMS. Researchers use a special brain scanner (TD-fNIRS) to see if patterns of brain activity can predict who will respond well to the treatment. Healthy volunte…
Sponsor: Kernel • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Robots map how brain and nerve injuries disrupt everyday arm tasks
Knowledge-focused Stopped earlyResearchers at the University of Pennsylvania are studying how people with stroke, upper limb amputation, spinal cord injury, or cerebral palsy move their arms during common daily activities like drinking and pouring. The study uses two passive desktop robots to track the motion …
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
20-Year review of lymphoma care reveals Real-World treatment success
Knowledge-focused Stopped earlyThis study examines the medical records of 400 people diagnosed with various types of lymphoma at a French hospital between 1999 and 2018. Researchers want to see how long patients survived and whether the care they received matched what medical guidelines recommend. The goal is …
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Brain scans reveal sex differences in THC effects for cannabis users
Knowledge-focused Stopped earlyThis study looks at how men and women with cannabis use disorder react differently to THC, the main psychoactive ingredient in cannabis. Researchers will give 40 adults either a THC pill or a placebo and use brain scans to measure changes in reward-related brain activity. The goa…
Phase 2 • Sponsor: Medical University of South Carolina • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Can sex boost the odds of IVF success?
Knowledge-focused Stopped earlyThis trial asks whether having sexual intercourse in the 72 hours after a frozen embryo transfer changes the likelihood of a clinical pregnancy. Researchers will compare pregnancy rates, miscarriage rates, and live birth rates between women who have sex and those who do not. The …
Sponsor: Fundación Santiago Dexeus Font • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Can a blood test or Mini-Tumor predict immunotherapy success in lung cancer?
Knowledge-focused Stopped earlyThis study is testing whether special lab tools—like analyzing tiny particles from blood cells or growing mini-tumors in a dish—can predict how well immunotherapy drugs work in people whose lung cancer has returned. About 40 participants will receive standard immunotherapy drugs …
Phase 1/2 • Sponsor: GlaxoSmithKline • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Tracing a cancer Drug's path through the body
Knowledge-focused Stopped earlyThis early-phase study by AstraZeneca examines how the experimental drug ceralasertib is absorbed, distributed, and eliminated in people with advanced solid tumors. Participants receive the drug orally and a tiny radiolabeled intravenous dose to track its journey. Researchers mea…
Phase 1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Can personalized recall timing boost word learning in kids with DLD?
Knowledge-focused Stopped earlyThis study explores whether tailoring when children with developmental language disorder (DLD) practice recalling new words can improve their learning. Researchers compare a standard fixed schedule to an adaptive one that adjusts to each child's progress. Four- and five-year-olds…
Sponsor: Purdue University • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Prostate cancer Therapy's hidden heart risk: new study investigates
Knowledge-focused Stopped earlyThis study looked at 10 men to understand why androgen deprivation therapy (ADT) for prostate cancer can lead to high blood pressure. Researchers checked if problems with the nervous system or kidneys were to blame. The goal is to find ways to prevent heart disease in prostate ca…
Phase 4 • Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Can new home monitors keep tabs on breathing support without a clinic visit?
Knowledge-focused Stopped earlyThis trial tests two new devices, NivolisMonitor and NivolisAnton, designed for people who use breathing support at home, such as non-invasive ventilation or high-flow nasal oxygen. NivolisMonitor measures breathing parameters like pressure, flow, and oxygen levels, while Nivolis…
Sponsor: VIVARDIS • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Exercise may alter gut bacteria in colon cancer survivors, small study hopes to find out
Knowledge-focused Stopped earlyThis study tests whether a moderate-to-vigorous exercise program can change the gut bacteria of people who have survived stage II or III colorectal cancer. Researchers will enroll 30 survivors and randomly assign them to either an exercise group or a health education group. The m…
Sponsor: Fred Hutchinson Cancer Center • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
5-Year check: does this stomach procedure keep weight off?
Knowledge-focused Stopped earlyThis study looks at people who had an endoscopic sleeve gastroplasty (ESG) at least 5 years ago to see if they kept the weight off. Researchers will measure total body weight loss at the 5-year mark. The goal is to understand the long-term success of this weight-loss procedure.
Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Helping with food and housing may boost cancer screening Follow-Up
Knowledge-focused Stopped earlyThis study looked at whether providing support for unmet basic needs—like food, housing, or transportation—helps low-income women attend their colposcopy appointment after an abnormal cervical cancer screening. The trial planned to enroll 72 participants but was stopped early wit…
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Can genetics predict the worsening of geographic atrophy?
Knowledge-focused Stopped earlyThis study follows people with geographic atrophy, a severe form of age-related macular degeneration that causes blind spots, to see how their vision changes over time. Researchers will measure visual function, such as reading speed and sensitivity to light, and track the growth …
Sponsor: Hoffmann-La Roche • Aim: Knowledge-focused
Last updated Aug 28, 2026 00:00 UTC
-
Ultrasound could uncover hidden vascular risks in turner syndrome
Knowledge-focused Stopped earlyThis study is looking at whether yearly ultrasound scans can detect blood vessel abnormalities throughout the body in women with Turner syndrome, not just in the heart area. Turner syndrome is a genetic condition that increases the risk of serious vascular problems, which can sho…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
Gene Editing's lasting impact: a 10-Year safety watch
Knowledge-focused Stopped earlyThis study checks on people who previously received gene editing for hemophilia B or mucopolysaccharidosis (MPS) I or II. No new treatment is given; instead, participants are monitored for up to 10 years to see if any new health problems or worsening of existing conditions appear…
Sponsor: Sangamo Therapeutics • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Can a coordinated care team ease the aftermath of intensive care?
Knowledge-focused Stopped earlyThis pilot study tests a new approach to supporting people after a stay in the intensive care unit (ICU). Many ICU survivors face ongoing psychological and physical challenges, such as depression, anxiety, and disability. The intervention involves a case manager who coordinates a…
Sponsor: Region Stockholm • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
MRI might reveal hidden pancreatic risks in obesity
Knowledge-focused Stopped earlyThis study investigates whether MRI can detect early signs of pancreatic damage linked to obesity and metabolic syndrome, which are risk factors for pancreatic cancer. Researchers will compare MRI images with tissue samples from patients undergoing pancreatic surgery, as well as …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Fat Tissue's hidden powerhouse: location may shape metabolism
Knowledge-focused Stopped earlyThis study investigates how the location of fat tissue in the body—under the skin versus around the organs—affects the function of mitochondria, the energy-producing parts of cells. Researchers will collect small samples of fat tissue from patients undergoing certain abdominal su…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Can a french questionnaire unlock the secrets of food cravings?
Knowledge-focused Stopped earlyThis study tests whether a French version of the Leeds Food Preference Questionnaire (LFPQ) accurately measures food reward—the psychological drive to eat certain foods. Researchers will ask lean and obese adults to complete the questionnaire before and after a meal, repeating th…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Biopsies may reveal why some cancers respond to immunotherapy
Knowledge-focused Stopped earlyThis study is looking at whether tumor biopsies can help predict which patients with melanoma, non-small cell lung cancer, or head and neck cancer will respond to immunotherapy drugs called PD-1 or PD-L1 inhibitors. Researchers will collect tissue samples from about 152 adults be…
Sponsor: UNICANCER • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
Heart valve repair may unlock better drug dosing for heart failure
Knowledge-focused Stopped earlyThis registry tracks people with severe functional mitral regurgitation and heart failure who undergo a minimally invasive mitral valve repair called M-TEER. The goal is to see whether the repair allows patients to tolerate higher, guideline-recommended doses of heart failure med…
Sponsor: Institut für Pharmakologie und Präventive Medizin • Aim: Knowledge-focused
Last updated Aug 01, 2026 00:00 UTC
-
Can 3D image fusion make angioplasty safer by cutting radiation?
Knowledge-focused Stopped earlyThis trial investigates whether using 3D image fusion during iliac angioplasty reduces the amount of radiation patients receive compared to standard practice. The study involves 37 adults with iliac artery narrowing who need angioplasty. Researchers will measure radiation exposur…
Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
Brain electrode recordings during awake surgery could sharpen tumor removal
Knowledge-focused Stopped earlyThis study investigates whether recording brain electrical activity during awake surgery can help identify networks involved in thinking and language. In people with glial brain tumors located in critical functional areas, surgeons place electrode grids on the brain before waking…
Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
Tiny study scratches surface of heart attack complication
Knowledge-focused Stopped earlyThis study looked at why some people who have a heart attack develop extra fluid around the heart (pericardial effusion). Researchers planned to use MRI scans to see if the amount of fluid was linked to other health factors and to survival one year later. Only 3 people took part …
Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
Aged heart cells may hold clues to heart disease progression after attack
Knowledge-focused Stopped earlyThis study looks at whether heart cells that age rapidly after a heart attack release harmful proteins that make heart disease worse. Researchers will collect blood and heart tissue samples from people undergoing coronary artery bypass surgery after a recent heart attack or for s…
Sponsor: South Tees Hospitals NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC
-
Hidden heart rhythm disorder may be behind many unexplained strokes
Knowledge-focused Stopped earlyThis study looks at people who had a stroke or mini-stroke with no known cause (cryptogenic stroke). Researchers want to see if a small device implanted under the skin, called an implantable loop recorder, can detect hidden atrial fibrillation — an irregular heart rhythm that can…
Sponsor: University of Valencia • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
Why kidney disease drains your strength: scientists probe muscle fatigue
Knowledge-focused Stopped earlyThis study investigates why people with advanced chronic kidney disease (stages 3b to 5) often feel tired and weak. Researchers measure handgrip strength and muscle electrical signals in patients aged 60 and older, comparing them to healthy individuals of the same age and sex. Th…
Sponsor: Centre Hospitalier le Mans • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
What drives cancer patients to try alternative therapies? a new survey seeks answers
Knowledge-focused Stopped earlyThis study surveys colorectal cancer patients about their use of complementary and alternative medicines (CAM), such as acupuncture, homeopathy, or dietary supplements. Researchers aim to understand which patients use CAM, why, and how it might affect their quality of life and ca…
Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Real-World data on brain aneurysm device could improve patient safety
Knowledge-focused Stopped earlyThis study observes people who have already been treated with the Pipeline Embolization Device for brain aneurysms. Researchers track neurological complications like stroke or bleeding to better understand the device's safety in everyday use. The goal is to expand knowledge on ho…
Sponsor: Medtronic Neurovascular Clinical Affairs • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Biopsy tolerance study ends early – what we know
Knowledge-focused Stopped earlyThis study aimed to understand how well patients tolerate biopsies for autoimmune diseases and whether they feel properly informed. It planned to enroll 505 people but was terminated early. The results may help improve patient experience with these common procedures.
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
New MRI scans reveal hidden brain changes after first MS symptoms
Knowledge-focused Stopped earlyThis study used a special MRI technique to look at tiny brain changes in people who recently had a first episode of symptoms that could lead to multiple sclerosis (MS). Researchers compared 84 participants (patients and healthy controls) to see if early memory problems are linked…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Newborn death prediction tool for early membrane rupture falls short
Knowledge-focused Stopped earlyThis study tried to create a score that doctors could use before birth to predict whether a newborn would die after the mother's water broke very early (between 22 and 28 weeks of pregnancy). The researchers looked back at medical records of 34 women to find factors that might pr…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Liver damage study in head and neck cancer abandoned after just 2 patients
Knowledge-focused Stopped earlyThis study aimed to find out how often liver fibrosis and cirrhosis occur in people with head and neck cancer, since tobacco and alcohol are risk factors for both. Researchers planned to check liver health using exams and imaging. However, the study was stopped early after only 2…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Alcohol and cirrhosis: can a quick test spot brain problems?
Knowledge-focused Stopped earlyThis study aimed to see if a short test called BEARNI could detect alcohol-related cognitive impairments (like memory and thinking problems) in people with alcoholic cirrhosis. The researchers planned to enroll patients with cirrhosis, but the study was stopped early after only o…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
HIV patients may age faster: study probes skin, muscle, and bone health
Knowledge-focused Stopped earlyThis study compared signs of aging in 123 HIV-infected adults to the general population. Researchers measured bone density, muscle strength, skin changes, and thinking abilities. The goal was to understand if HIV speeds up aging in these areas. No new treatment was tested; it was…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Tiny study on diuretics after heart surgery ends early
Knowledge-focused Stopped earlyThis study looked at how diuretics (water pills) affect kidney and heart function in people who just had heart surgery. The goal was to see if removing extra fluid changes how well the kidneys and right side of the heart work. Only 9 people took part, and the study was stopped ea…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Skin microbes linked to vitiligo and immunotherapy reactions in melanoma patients
Knowledge-focused Stopped earlyThis study explores whether the community of bacteria living on the skin (the skin microbiome) plays a role in vitiligo—a condition that causes white patches—and in side effects from anti-PD-1 immunotherapy for advanced melanoma. Researchers will collect skin swabs from people wi…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Teen obesity linked to brain changes in emotional memory
Knowledge-focused Stopped earlyThis study looked at how being obese as a teenager might affect emotional memory and the connections between two key brain areas: the amygdala and hippocampus. Researchers compared obese and normal-weight adolescents aged 12-17 using MRI scans while they performed memory tasks. T…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
COVID-19 vaccine safety checked in cancer immunotherapy patients
Knowledge-focused Stopped earlyThis study aimed to see if COVID-19 vaccines cause more side effects in cancer patients receiving immunotherapy. Researchers planned to track 125 patients from several hospitals in France, recording any local or systemic side effects. The study was terminated early, so the full r…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
New study explores simple tests to replace colonoscopies for colitis patients
Knowledge-focused Stopped earlyThis study aimed to see if certain substances in stool and blood can predict whether the gut lining has healed in people with moderate to severe ulcerative colitis. Researchers planned to measure these markers in 62 adults before and after treatment. The study was terminated earl…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Hysterectomy study abandoned after just one patient
Knowledge-focused Stopped earlyThis study aimed to compare how often women could go home the same day after a hysterectomy using three different minimally invasive techniques: vNOTES (through the vagina), conventional laparoscopy, and robot-assisted laparoscopy. The trial was terminated early after enrolling o…
Sponsor: Elsan • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can brain training help depressed young adults stop ruminating?
Knowledge-focused Stopped earlyThis study tested whether real-time fMRI neurofeedback could help young adults with major depression reduce repetitive negative thinking. Participants received either real or fake feedback while their brain activity was monitored. The trial was terminated early, so the findings a…
Sponsor: Laureate Institute for Brain Research, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Heart attack aftermath: can a PET scan predict who will develop heart failure?
Knowledge-focused Stopped earlyThis study aimed to understand why some people develop heart failure after a heart attack. Researchers used special PET scans and blood tests to measure blood vessel function and scarring in the heart muscle of 30 patients who had a first heart attack. The goal was to see if thes…
Sponsor: University Hospital, Caen • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Laughing gas linked to nerve damage in young users
Knowledge-focused Stopped earlyThis study looked back at 20 young people who came to the hospital with nerve problems after using nitrous oxide (laughing gas) for fun. Researchers measured muscle strength, balance, and disability to understand how the gas harms the nervous system. The goal was to learn more ab…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Fabry disease sperm study halted early
Knowledge-focused Stopped earlyThis study aimed to find out how common sperm problems are in men with Fabry disease. Researchers planned to check sperm samples from 22 men aged 18 to 65. The study was stopped early, so results are limited.
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Tiny study hopes to predict blood cancer risk from genetic mutations
Knowledge-focused Stopped earlyThis study aimed to find genetic mutations in people with idiopathic cytopenia of undetermined significance (ICUS), a condition of unexplained low blood cell counts. Researchers wanted to see if these mutations are similar to those found in myelodysplastic syndrome (MDS), a type …
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Ultrasound guidance for central lines in obese ICU patients: a terminated study
Knowledge-focused Stopped earlyThis study looked at whether using ultrasound to guide central venous catheter placement reduces complications in obese intensive care unit patients. Researchers planned to include 450 patients, but the study was terminated early. The goal was to compare complication rates betwee…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:08 UTC
-
Stroke study seeks brain regions to boost arm healing
Knowledge-focused Stopped earlyThis study aimed to identify brain areas outside the main motor region that help arm recovery after a severe stroke. Researchers followed 28 patients over time, using MRI and movement tracking to see which brain areas became active as arm function improved. The goal was to find n…
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:08 UTC
-
Could a common virus trigger thyroid troubles?
Knowledge-focused Stopped earlyThis study investigated whether polyomaviruses (a type of common virus) are found more often in people with autoimmune thyroiditis or goiters. Researchers compared virus presence in blood, urine, and thyroid tissue from 49 patients undergoing thyroid surgery. The goal was to see …
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Brain and eye clues to emotion recognition in autism and psychosis
Knowledge-focused Stopped earlyThis study aimed to understand why people with autism or schizophrenia sometimes struggle to recognize emotions on faces. Researchers used brain wave recordings (EEG) and eye-tracking to see how participants processed facial expressions. The study included people with autism, sch…
Sponsor: Hôpital le Vinatier • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Brain zapping study halted early – what it means for mental health
Knowledge-focused Stopped earlyThis study looked at how noninvasive brain stimulation techniques like rTMS, tDCS, and ECT change BDNF levels in people with depression or schizophrenia. Researchers took blood samples before and after stimulation to measure BDNF, a protein linked to brain health. The study was t…
Sponsor: Hôpital le Vinatier • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Scientists collect samples from COVID-19 patients to unlock virus secrets
Knowledge-focused Stopped earlyThis study collected blood, urine, stool, and respiratory samples from 615 COVID-19 patients and caregivers at Bordeaux University Hospital. The goal was to build a biobank for research on the virus and disease. The study was terminated early, but the samples may still help scien…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Does Dad's smoking harm fertility? new study investigates
Knowledge-focused Stopped earlyThis study looked at how a man's smoking habits might affect a couple's ability to have a baby. Researchers compared fertile and infertile couples, measuring smoking markers like carbon monoxide and cotinine in blood, semen, and hair. The goal was to understand if smoking damages…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Tiny hairs in fallopian tubes may hold key to ectopic pregnancy
Knowledge-focused Stopped earlyThis study looks at the tiny hair-like structures (cilia) inside the fallopian tubes of women who have had surgery to remove a tube or uterus. Researchers want to see if differences in these cilia help explain why some women have ectopic pregnancies (when a fertilized egg grows o…
Sponsor: Centre Hospitalier Intercommunal Creteil • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Hip replacement study halted early: what it means for pelvic movement
Knowledge-focused Stopped earlyThis study aimed to see how total hip replacement changes the way the pelvic bone moves during daily activities like sitting and standing. Researchers used an ultrasound device to measure pelvic tilt in 15 people with hip arthritis before and after surgery. The study was terminat…
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Scientists dive into cells to unravel costello Syndrome's secrets
Knowledge-focused Stopped earlyThis study collects small skin samples from children aged 2 to 17 with Costello syndrome or a related condition. Researchers will analyze the cells to understand how a mutation in the HRAS gene affects energy use and mitochondria. The goal is to learn more about the disease's und…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Tiny study on eye pressure fluctuation in glaucoma patients ends early
Knowledge-focused Stopped earlyThis study aimed to measure how eye volume changes (a sign of pressure fluctuation) before and after cataract surgery in patients with exfoliative glaucoma, a type of glaucoma common in Brittany. Only 6 adults were enrolled before the study was terminated. The goal was to see if …
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
MRI vs. CT: a safer way to track cystic fibrosis lung health?
Knowledge-focused Stopped earlyThis study looked at whether MRI scans can detect changes in the lungs of people with cystic fibrosis as well as CT scans do. CT scans use radiation, so finding a reliable alternative like MRI could mean safer monitoring over time. The study included 212 patients aged 8 and older…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
COVID-19 may harm the brain in ways scans Can't see
Knowledge-focused Stopped earlyThis study looked for hidden brain damage in 38 hospitalized COVID-19 patients. Instead of using standard MRI scans, researchers used electrical tests to check how well the brainstem was working. The goal was to find subtle nervous system problems that might not show up on regula…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Smart soles could track walking trouble in nerve disease
Knowledge-focused Stopped earlyThis study tested whether special insoles with pressure sensors (FEETME®) can accurately measure walking speed in people with CIDP, a nerve condition that causes walking difficulties. Researchers compared the insoles to a standard walkway system in 18 adults aged 18-75 with CIDP.…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Antibiotic resistance explored in myeloma stem cell transplants
Knowledge-focused Stopped earlyThis study aimed to find out how common antibiotic resistance is in multiple myeloma patients receiving a stem cell transplant. Researchers planned to collect data from 124 adults to help design future studies on preventing infections. The study was stopped early, so results are …
Sponsor: Hackensack Meridian Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Sleep study for ICU sedation halted after just 3 volunteers
Knowledge-focused Stopped earlyThis study aimed to see if a sedative called dexmedetomidine produces sleep more like natural sleep than another sedative, propofol. Researchers planned to measure brain activity in 3 healthy volunteers during drug-induced and natural sleep. The trial was terminated early, so onl…
Phase 1 • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Web tool aims to ease tough COVID conversations
Knowledge-focused Stopped earlyThis study tested a web-based guide to help people have conversations about COVID-19. It enrolled 30 adults who spoke English or Spanish. The guide offered virtual conversations tailored to different concerns. The study was terminated early, so results are limited.
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Tiny nerves may explain chronic cough in diabetes
Knowledge-focused Stopped earlyThis study looked at whether people with type 2 diabetes who have a chronic cough also have damage to small nerves in their skin. Researchers compared diabetic patients with and without chronic cough using nerve tests and skin biopsies. The study was terminated early with only 7 …
Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Can a chatbot replace your Post-Surgery doctor visit?
Knowledge-focused Stopped earlyThis pilot study tested whether remote check-ups (using a chatbot questionnaire and video calls) could work as well as in-person visits for people who had weight-loss surgery. Only 7 adults living far from the hospital took part. The goal was to see if this approach could improve…
Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Brain injury and ARDS: which breathing maneuver is safer?
Knowledge-focused Stopped earlyThis study compared two breathing techniques (CPAP and eSigh) in 18 patients with brain injury and acute respiratory distress syndrome (ARDS). The goal was to see which method better maintains oxygen levels in the brain without causing harm. The trial was terminated early, so fin…
Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New imaging technique could let doctors see lung Cancer's inner workings in real time
Knowledge-focused Stopped earlyThis early-phase study tested whether two optical imaging agents could be used during a bronchoscopy to visualize activated neutrophils and a cancer-related protein called c-MET in lung tumors. Five participants with lung cancer received the agents through a special catheter whil…
Early phase 1 • Sponsor: University of Edinburgh • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Wearable tag aims to spot heart failure patients at risk of returning to hospital
Knowledge-focused Stopped earlyThis pilot study tested whether a small wearable sensor called the Spire Health Tag could reliably track heart rate, activity, sleep, and stress in heart failure patients after they leave the hospital. The goal was to see if the device could capture useful data for at least 80% o…
Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Tiny study probes how heart rebounds after brief artery blockage
Knowledge-focused Stopped earlyThis study looked at how the heart's pumping function recovers after a short, controlled blockage of a coronary artery using a balloon. Six adults with stable coronary artery disease undergoing angioplasty had a balloon inflated in their artery for 90 seconds. Researchers measure…
Sponsor: Vastra Gotaland Region • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Brain scans reveal how autistic people process sensory overload
Knowledge-focused Stopped earlyThis study aimed to understand why people with autism often feel overwhelmed by sensory input like bright lights or loud noises. Researchers planned to use virtual reality and brain scans to see how the brain reacts to unpleasant visual stimuli. The study was terminated early and…
Sponsor: University of Nebraska • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Heart surgery oxygen study halted after just 6 patients
Knowledge-focused Stopped earlyThis study aimed to understand how oxygen delivery changes during heart surgery when a heart-lung machine is used. Researchers wanted to create a computer model to help doctors personalize oxygen levels for each patient, potentially reducing complications like kidney injury. Only…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
New tool could help patients stay safe on lithium
Knowledge-focused Stopped earlyThis study tested a French version of a questionnaire that measures how much patients know about lithium, a drug used for bipolar and schizoaffective disorders. Researchers wanted to see if higher knowledge scores matched safe lithium levels in the blood. The study included 22 ho…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Tiny brain wave study aims to sharpen Alzheimer's drug testing
Knowledge-focused Stopped earlyThis pilot study measured brain activity (EEG) in 6 healthy volunteers while they performed computer tasks that test attention and memory. The goal was to develop better ways to measure thinking skills that could be used in future Alzheimer's drug trials. The study was terminated…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Tiny genetic clues may unlock eye disease mysteries
Knowledge-focused Stopped earlyThis study looked at people with cone disorders, a type of inherited eye disease that affects color vision and sharp sight. Researchers analyzed genetic changes of unknown significance to see if they cause disease. The goal was to improve genetic diagnosis, not to test a treatmen…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Stroke's hidden toll: brain scans reveal emotion perception changes
Knowledge-focused Stopped earlyThis study looked at how stroke changes the brain's ability to recognize emotions like fear and happiness. Researchers used MRI and EEG to compare stroke patients with healthy volunteers. The study was stopped early and only included 2 participants, so findings are very limited.
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Sleep troubles linked to suicide attempts? study investigates
Knowledge-focused Stopped earlyThis study looked at whether sleep disorders like insomnia and nightmares are connected to suicide attempts. Researchers compared people who had just attempted suicide with those who had suicidal thoughts but no attempt. The goal was to see if sleep problems might be a trigger. T…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC